Decision Resources, Inc. News Decision Resourcs, Inc. News RSS Feed <![CDATA[New Executive Briefing: Sifting through the noise: How the exchanges and ACOs are changing healthcare dynamics in the U.S., one market at a time]]> ]]> Wed, 05 Jun 2013 09:54:19 GMT <![CDATA[Post-ACA Implementation Brings Opportunity and Uncertainty to Pharmaceutical Companies Looking to Capture Growth in New Places]]> ]]> Wed, 08 May 2013 13:10:57 GMT <![CDATA[Post-ACA Implementation Brings Opportunity and Uncertainty to Pharmaceutical Companies Looking to Capture Growth in New Places]]> ]]> Wed, 08 May 2013 13:10:57 GMT <![CDATA[Panelists Announced for Decision Resources Group One-Day Biologics and Biosimilars Seminar in San Diego]]> Thu, 18 Apr 2013 09:48:23 GMT <![CDATA[Panelists Announced for Decision Resources Group One-Day Biologics and Biosimilars Seminar in San Diego]]> Thu, 18 Apr 2013 09:48:23 GMT <![CDATA[Decision Resources Analyst Anne-Elise Tobin, Ph.D. quoted on Nature.com web site]]> Antibody drugs set to revive flagging migraine target
CGRP makes a comeback as antibodies advance into Phase II trials.
]]> Mon, 01 Apr 2013 00:00:00 GMT <![CDATA[Decision Resources Product Manager Roy Moore quoted on Information Week web site]]> Docs Who E-Prescribe Order More Generics, Study Says
Putting drug details in front of doctors, combined with incentive programs for generics, is steering prescriptions toward low-cost medicine.
]]> Wed, 20 Mar 2013 00:00:00 GMT <![CDATA[BioTrends Research Group Director Andrew Merron, Ph.D. quoted on The Indianapolis Star web site]]> Eli Lilly, insurers at odds over new type of drug
One state legislator said she had never seen so many lobbyists testify on a single-issue bill.
]]> Fri, 15 Mar 2013 00:00:00 GMT <![CDATA[BioTrends Research Group Director Andrew Merron, Ph.D. quoted on The Indianapolis Star web site]]> Eli Lilly, insurers at odds over new type of drug
One state legislator said she had never seen so many lobbyists testify on a single-issue bill.
]]> Fri, 15 Mar 2013 00:00:00 GMT <![CDATA[Seminar Spotlights Key Trends in Biologics and Biosimilars]]> Tue, 12 Mar 2013 11:40:21 GMT <![CDATA[Seminar Spotlights Key Trends in Biologics and Biosimilars]]> Tue, 12 Mar 2013 11:40:21 GMT <![CDATA[Decision Resources Senior Director Donny Wong, Ph.D. quoted on EverydayHealth.com web site]]> Long-Term Benefits, Risks of Newest Diabetes Drugs Still Unclear
New data shows the latest class of diabetes drugs may protect against heart failure, but the long-term health benefits and risks require more study.
]]> Sun, 10 Mar 2013 00:00:00 GMT <![CDATA[Decision Resources Senior Director Conor Walsh, Ph.D. and Analyst Eamonn O’Connor, Ph.D. quoted on New Jersey Star Ledger web site]]> Janssen will begin clinical trials for expanded use of Xarelto blood thinner
Janssen Pharmaceuticals announced today it will launch a global research program to evaluate the expanded uses of its blood thinner Xarelto, days after the drug failed to win approval to prevent heart attacks and strokes.
]]> Fri, 08 Mar 2013 00:00:00 GMT <![CDATA[Decision Resources Analyst Seamus Levine-Wilkinson, Ph.D. quoted on BioWorld web site]]> Medivir, Gilead Oral Drug Pair Strong in HCV, Early Phase IIa
Their oral combo drug's 100 percent success rate in hepatitis C virus (HCV) patients with liver fibrosis did not do much for shares of Medivir AB and partner Gilead Sciences Inc., probably because the positive interim results from the Phase IIa trial were "baked in" by investors, who must wait to find out more.
]]> Tue, 05 Mar 2013 00:00:00 GMT <![CDATA[BioTrends Research Group Therapeutic Class Director Daniel Winkelman quoted in The Pink Sheet and pinksheet.com web site]]> Beyond Herceptin: Kadcyla Carries Torch Across Lines Of HER2 Therapy
With the approval of its Herceptin -containing antibody drug conjugate Kadcyla (T-DM1), Roche / Genentech Inc. is moving closer to the goal of managing HER2-positive breast cancer patients across multiple lines of therapy.
]]> Mon, 04 Mar 2013 00:00:00 GMT <![CDATA[Decision Resources Senior Director Donny Wong, Ph.D. quoted in Nature magazine and nature.com web site]]> Cholesterol limits lose their lustre
Revised guidelines for heart health are set to move away from target-based approach.
]]> Tue, 26 Feb 2013 00:00:00 GMT <![CDATA[Decision Resources Senior Director Donny Wong, Ph.D. quoted on Barrons.com web site]]> Novo's Pain Means Sanofi Shares Gain
The FDA's recent refusal to approve Novo Nordisk's new diabetes drug puts the pricey ADRs at risk, and opens the door to more profits for rival Sanofi.
]]> Thu, 21 Feb 2013 00:00:00 GMT <![CDATA[The Annual Managed Markets Summit Opens Next Week in Miami]]> ]]> Tue, 19 Feb 2013 10:44:15 GMT <![CDATA[The Annual Managed Markets Summit Opens Next Week in Miami]]> ]]> Tue, 19 Feb 2013 10:44:15 GMT <![CDATA[Decision Resources Analyst Khurram Nawaz quoted on FiercePharma web site]]> New Celgene drug packs punch for multiple myeloma market
The market for multiple myeloma drugs has been forecast to grow 60% by 2021, reaching more than $7 billion from about $4.4 billion.
]]> Sun, 10 Feb 2013 00:00:00 GMT <![CDATA[HealthLeaders-InterStudy Analyst April Wortham quoted on The Commercial Appeal web site]]> Former Tennessee Health Commissioner Susan Cooper settles into new role at The Med
Susan Cooper is glad she doesn't have to answer the phone at 3 a.m. anymore. But she wants it made clear that when her phone does ring, it rings in Memphis.
]]> Thu, 07 Feb 2013 00:00:00 GMT <![CDATA[Decision Resources Senior Director Donny Wong, Ph.D. quoted on Genetic Engineering & Biotechnology News web site]]> Type 2 Diabetes Drugs Drive Sector Growth
Firms Use a Range of Strategies to Exploit a Market Expected to Grow to $157B by 2017.
]]> Fri, 01 Feb 2013 00:00:00 GMT <![CDATA[HealthLeaders-InterStudy Analyst Joel Peyton quoted in Crain’s Chicago Business journal and chicagobusiness.com web site]]> Health insurers propose double-digit rate hikes
While premiums for many small-group plans in Illinois are expected to rise 5 percent to 7 percent this year, some consumers will be socked by double-digit rate hikes.
]]> Tue, 22 Jan 2013 00:00:00 GMT <![CDATA[Decision Resources Analyst Eamonn O’Connor, Ph.D. quoted in Drug Benefit News and AIS Health web site]]> Health Plans Keep Watchful Eye on ‘New Generation’ Blood-Thinning Therapies
Nearly 60 years ago, warfarin was approved for use as a blood-thinning agent for the prevention of thrombosis and embolism in many disorders and still remains the most widely prescribed oral anticoagulant drug in the U.S.
]]> Thu, 17 Jan 2013 00:00:00 GMT <![CDATA[BioTrends Research Group data quoted on Nephrology News & Issues web site]]> Survey shows decreased ESA use for dialysis, chronic kidney disease patients
A recent BioTrends Research Group survey of 306 U.S. nephrologists found that the use of erythropoietin-stimulating agents in dialysis patients is declining.
]]> Tue, 15 Jan 2013 00:00:00 GMT <![CDATA[Decision Resources Director Benjamin Guikema, Ph.D. quoted on Specialty Pharmacy Times web site]]> Increased Uptake of Hepatitis B Drugs Expected in the Coming Years
Uptake of oral nucleoside/nucleotide analogues will increase from 2011 to 2021, according to new research from Decision Resources.
]]> Tue, 15 Jan 2013 00:00:00 GMT <![CDATA[Decision Resources Analyst Jing Wu quoted in PharmAsia News and Elsevier Business News web site]]> China Seen As The Prize In The Race For HCV Dominance
As Gilead and AbbVie battle for new hepatitis C treatment options, Roche is hoping a trailing product can find a home in China, where genotype 1b HCV is most prevalent.
]]> Fri, 11 Jan 2013 00:00:00 GMT <![CDATA[Decision Resources Therapeutic Area Director Donny Wong, Ph.D. quoted in The Financial Times]]> Pharma groups hope for diet drugs binge
As Christmas overeating gives way to under-fulfilled new year diets, the pharmaceutical industry’s appetite has been whetted for a fresh surge in business.
]]> Wed, 26 Dec 2012 00:00:00 GMT <![CDATA[Decision Resources Product Manager, Roy Moore, quoted in Specialty Pharmacy Times ]]> Clinical Pathways May Factor into ACO Reimbursement Strategies
The adoption of clinical pathways in oncology has the potential to streamline care. Breast cancer, colorectal cancer, and non-small-cell lung cancer appear to be the conditions that are the current priorities for pathway programs, according to a new report from Decision Resources entitled, “Impact of Payer-Imposed Strategies on Market Access in Oncology: Clinical Pathways, Accountable Care Organization Contracting, Specialty Pharmacy, and the Evolution of the Buy and Bill Model.”

]]> Thu, 20 Dec 2012 13:37:54 GMT <![CDATA[Decision Resources Product Manager, Roy Moore, quoted in Specialty Pharmacy Times ]]> Clinical Pathways May Factor into ACO Reimbursement Strategies
The adoption of clinical pathways in oncology has the potential to streamline care. Breast cancer, colorectal cancer, and non-small-cell lung cancer appear to be the conditions that are the current priorities for pathway programs, according to a new report from Decision Resources entitled, “Impact of Payer-Imposed Strategies on Market Access in Oncology: Clinical Pathways, Accountable Care Organization Contracting, Specialty Pharmacy, and the Evolution of the Buy and Bill Model.”
]]> Thu, 20 Dec 2012 13:37:54 GMT <![CDATA[BioTrends Research Group Therapeutic Class Director Rob Dubman quoted on BioWorld Today]]> FibroGen, Astellas Open Wide: Oral Anemia Drug to Phase III $50M Milestone for FibroGen
Wading into Phase III waters with a new class of anemia drugs, FibroGen Inc. and partner Astellas Pharma Inc. hope to show benefit with their orally given drug not only in the condition related to chronic kidney disease (CKD), but also in hypertension and elevated cholesterol.
]]> Thu, 13 Dec 2012 00:00:00 GMT <![CDATA[Decision Resources Group Acquires Abacus International]]> ]]> Tue, 04 Dec 2012 08:29:40 GMT <![CDATA[Decision Resources Group Acquires Abacus International]]> ]]> Tue, 04 Dec 2012 08:29:40 GMT <![CDATA[HealthLeaders-InterStudy Analysts Chris Lewis and Ric Gross quoted in The Boston Globe]]> Harvard Pilgrim seeks to expand into Connecticut
Insurer sees federal health care law as chance to grow
]]> Wed, 28 Nov 2012 08:56:31 GMT <![CDATA[Manhattan Research Vice President Monique Levy quoted in MobiHealthNews]]> Apple’s top 80 apps for doctors, nurses, patients
Based on the more rigorous surveys and reports, it’s still true that clinicians are generally more eager adopters of both mobile devices and the medical apps that run on them.
]]> Tue, 27 Nov 2012 09:14:09 GMT <![CDATA[BioTrends Research Group data quoted in FierceBiotech]]> Survey: Many docs will be slow to switch to biosimilar mAbs
A large majority of oncologists around the world seem eager to switch their patients to biosimilar versions of ESA and G-CSF therapies once they become readily available, according to a new survey out from BioTrends Research Group.
]]> Mon, 29 Oct 2012 15:04:13 GMT <![CDATA[Manhattan Research Vice President Monique Levy quoted in iHealthBeat]]> How Many U.S. Adults Used Mobile Phones and Tablet Computers for Health-Related Activities?
Seventy-five million U.S. adults used mobile phones for health-related activities in 2012, up from 61 million in 2011, according to a recent report by Manhattan Research.
]]> Wed, 24 Oct 2012 15:06:43 GMT <![CDATA[BioTrends Research Group data quoted in FiercePharma]]> Novartis balks at Eylea-vs.-Lucentis data
Bayer and Regeneron ($REGN) are touting new data on their macular degeneration drug Eylea. And no wonder: The VIEW 1 and VIEW 2 studies found that Eylea matched rival drug Lucentis in head-to-head comparisons.
]]> Mon, 22 Oct 2012 15:04:13 GMT <![CDATA[Manhattan Research Vice President Monique Levy quoted in Information Week]]> More Consumers Get Health Info On Mobile Devices
Smartphones and tablets are playing a bigger role in healthcare, and more change will take place when providers connect with patients using mobile apps, healthcare experts say.
]]> Mon, 08 Oct 2012 16:55:09 GMT <![CDATA[Manhattan Research Vice President Monique Levy quoted in Information Week]]> More Consumers Get Health Info On Mobile Devices
Smartphones and tablets are playing a bigger role in healthcare, and more change will take place when providers connect with patients using mobile apps, healthcare experts say.
]]> Mon, 08 Oct 2012 16:55:09 GMT <![CDATA[Panelists Announced for Decision Resources Group One-day Biologics and Biosimilars Seminar in New York City]]> ]]> Tue, 25 Sep 2012 13:19:50 GMT <![CDATA[Medicaid is a Focus at Pinsonault Sixth Annual Managed Markets Summit]]> ]]> Wed, 29 Aug 2012 08:45:39 GMT <![CDATA[Medicaid is a Focus at Pinsonault Sixth Annual Managed Markets Summit]]> ]]> Wed, 29 Aug 2012 08:45:39 GMT <![CDATA[A Focus on Specialty Pharmacy at Las Vegas Pharmaceutical Conference]]> ]]> Wed, 15 Aug 2012 09:36:49 GMT <![CDATA[A Focus on Specialty Pharmacy at Las Vegas Pharmaceutical Conference]]> ]]> Wed, 15 Aug 2012 09:36:49 GMT <![CDATA[Mark Meek Named President of Decision Resources Group Biopharma Business Unit ]]> ]]> Wed, 08 Aug 2012 11:31:24 GMT <![CDATA[Mark Meek Named President of Decision Resources Group Biopharma Business Unit ]]> ]]> Wed, 08 Aug 2012 11:31:24 GMT <![CDATA[Manhattan Research Analyst James Avallone quoted in Med City News ]]> Device marketers have greater opportunity to digitally engage physicians than previously
Physicians are more than eager to interact digitally with makers of medical devices. That was the message that James Avallone, principal analyst with Manhattan Research, one of the speakers at the 2nd Annual Digital Marketing of Medical Devices Conference in Minneapolis, communicated Tuesday.
]]> Wed, 01 Aug 2012 15:39:47 GMT <![CDATA[Manhattan Research data quoted in Medical Marketing & Media]]> Pharma must reboot iPads
The pharmaceutical industry has joined the cult of Mac. Since the launch of the iPad in 2010, pharma companies have invested significant time and resources creating promotional materials on the device for use in detailing.
]]> Wed, 01 Aug 2012 15:34:02 GMT <![CDATA[Decision Resources Group to Present One-day Biologics and Biosimilars Seminar in New York City on October 4]]> ]]> Wed, 01 Aug 2012 09:23:57 GMT <![CDATA[Decision Resources Group to Present One-day Biologics and Biosimilars Seminar in New York City on October 4]]> ]]> Wed, 01 Aug 2012 09:23:57 GMT <![CDATA[Manhattan Research data quoted on iHealthBeat]]> Study: Nurses, PAs Use Health IT Tools More Often Than Physicians
Ancillary health care providers like nurses and physician assistants spend more time using electronic health record systems and other digital technology in their clinical work than physicians, according to a study by Manhattan Research.
]]> Fri, 27 Jul 2012 16:13:56 GMT <![CDATA[Decision Resources Pharmaview Director Alasdair Milton, Ph.D. quoted in FirstWord Pharma]]> ViewPoints: Why GlaxoSmithKline's acquisition of Human Genome Sciences remains a gamble
In a strange twist of fate, the acquisition of Human Genome Sciences will end up costing GlaxoSmithKline around $3 billion net of cash and debt; the same amount that the UK drugmaker recently agreed to pay as a settlement to the US federal government.
]]> Fri, 27 Jul 2012 11:00:38 GMT <![CDATA[Decision Resources Pharmaview Director Alasdair Milton, Ph.D. quoted in FirstWord Pharma]]> ViewPoints: Why GlaxoSmithKline's acquisition of Human Genome Sciences remains a gamble
In a strange twist of fate, the acquisition of Human Genome Sciences will end up costing GlaxoSmithKline around $3 billion net of cash and debt; the same amount that the UK drugmaker recently agreed to pay as a settlement to the US federal government.
]]> Fri, 27 Jul 2012 11:00:38 GMT <![CDATA[Keynote Speakers Announced For Sixth Annual Pinsonault Managed Markets Summit]]>
]]> Thu, 26 Jul 2012 14:31:53 GMT <![CDATA[Keynote Speakers Announced For Sixth Annual Pinsonault Managed Markets Summit]]>
]]> Thu, 26 Jul 2012 14:31:53 GMT <![CDATA[BioTrends Research Group Analyst Kate Keeping quoted in FirstWord Pharma]]> ViewPoints: Amgen shows first hand in biosimilars market – key observations
Amgen and Watson provided the first real insight into their strategy on Wednesday, when Synthon revealed that the two companies had entered into a global licensing agreement for its biosimilar version of Roche’s HER2-positive breast cancer treatment Herceptin (trastuzumab).
]]> Mon, 23 Jul 2012 15:04:13 GMT <![CDATA[BioTrends Research Group Analyst Kate Keeping quoted in FirstWord Pharma]]> ViewPoints: Amgen shows first hand in biosimilars market – key observations
Amgen and Watson provided the first real insight into their strategy on Wednesday, when Synthon revealed that the two companies had entered into a global licensing agreement for its biosimilar version of Roche’s HER2-positive breast cancer treatment Herceptin (trastuzumab).
]]> Mon, 23 Jul 2012 15:04:13 GMT <![CDATA[HealthLeaders-InterStudy Market Analyst April Wortham quoted on Nooga.com]]> BlueCross BlueShield of Tennessee, Memorial face off in reimbursement negotiations
Leaders with BlueCross BlueShield of Tennessee and Memorial Health Care System are at an impasse about how much reimbursement the health insurer will provide for hospital care.
]]> Fri, 20 Jul 2012 13:07:42 GMT <![CDATA[6th Annual Pinsonault Managed Markets Summit Addresses Critical Healthcare Trends This September in Las Vegas]]> ]]> Thu, 12 Jul 2012 10:02:53 GMT <![CDATA[6th Annual Pinsonault Managed Markets Summit Addresses Critical Healthcare Trends This September in Las Vegas]]> ]]> Thu, 12 Jul 2012 10:02:53 GMT <![CDATA[HealthLeaders-InterStudy Analyst April Wortham quoted on Nooga.com]]> Updated: Leaders react to health care reform ruling
After some confusing national news coverage on a complicated topic, made more muddled by social media explanations, leaders reacted to the Supreme Court ruling that the core of President Barack Obama’s health care reform act is constitutional.
]]> Thu, 28 Jun 2012 00:00:00 GMT <![CDATA[Decision Resources Group to Present One-Day Cardiovascular Competitive Landscape Seminar in Boston]]> ]]> Thu, 07 Jun 2012 09:09:34 GMT <![CDATA[Decision Resources Group to Present One-Day Cardiovascular Competitive Landscape Seminar in Boston]]> ]]> Thu, 07 Jun 2012 09:09:34 GMT <![CDATA[Manhattan Research Vice President Monique Levy quoted in American Medical News]]> Doctors quick to adopt tablets into practice
Most physicians own iPads or other tablet computers, and they are finding creative ways to integrate them into patient interactions and other aspects of medicine.
]]> Mon, 04 Jun 2012 00:00:00 GMT <![CDATA[Decision Resources Analyst Hiroshi Tashiro quoted in FirstWord Pharma]]> ViewPoints: Strength of Yen set to drive continued M&A activity from Japan
Japanese pharmaceutical manufacturers have been no strangers to M&A activity over the past decade, and recent comments by Takeda indicate that little change can be expected. Deals have focused initially on consolidation in the domestic market and subsequently shaped by international acquisitions.
]]> Mon, 21 May 2012 12:53:21 GMT <![CDATA[BioTrends Research Group Associate Director Kate Keeping quoted on FirstWord Pharma]]> Spotlight On: Presentation of biosimilar Remicade data at next month’s EULAR congress
As progression towards a workable biosimilars pathway in the US continues to hit roadblocks, Europe moves closer to the potential approval of the first biosimilar monoclonal antibody; a version of Remicade developed by the South Korean company Celltrion
]]> Fri, 18 May 2012 11:00:38 GMT <![CDATA[BioTrends Research Group Therapeutic Class Director Dan Winkelman quoted on Genomeweb]]> Molecular Screening Awareness Grows in Step with Adoption of Roche Melanoma Drug, Survey Finds
Zelboraf to treat metastatic melanoma patients whose tumors harbor BRAF gene mutations.
]]> Wed, 16 May 2012 15:04:13 GMT <![CDATA[Piramal Healthcare Limited to Acquire Decision Resources Group]]>
  • Decision Resources Group (DRG) acquisition at approximately US$635 Million
  • DRG a fast growing healthcare information business - CAGR 20% from 2006 to 2011
  • DRG’s client base includes 48 out of top 50 global pharma companies
    • ]]>     Wed, 16 May 2012 08:28:31 GMT     <![CDATA[Piramal Healthcare Limited to Acquire Decision Resources Group]]>
  • Decision Resources Group (DRG) acquisition at approximately US$635 Million
  • DRG a fast growing healthcare information business - CAGR 20% from 2006 to 2011
  • DRG’s client base includes 48 out of top 50 global pharma companies
    • ]]>     Wed, 16 May 2012 08:28:31 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted in Business Insider]]> Forget Television, These Are The Big Industries Apple Could Dominate Next
    Apple has a track record of dominating or disrupting major markets. Think PCs. Portable media players. Digital music. Smartphones. Tablets. Many have speculated in recent months that Apple will attempt to do the same to the television-set business with the launch of its much-rumored iTV.
    ]]>     Wed, 16 May 2012 00:00:00 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted in Information Week]]> Doctors' Tablet Use Almost Doubles In 2012
    Apple's iPad has emerged as the dominant tablet platform, according to Manhattan Research survey.
    ]]>     Wed, 16 May 2012 00:00:00 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted in Information Week]]> Doctors' Tablet Use Almost Doubles In 2012
    Apple's iPad has emerged as the dominant tablet platform, according to Manhattan Research survey.
    ]]>     Wed, 16 May 2012 00:00:00 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted on CMIO.net]]> Report: Docs are adopting tablets more than you think
    Physicians’ device and digital media adoption are evolving much faster than anticipated, especially when it comes to tablets, according to a May report from healthcare market research firm Manhattan Research.
    ]]>     Wed, 16 May 2012 00:00:00 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted in iHealthBeat]]> Report: Physician Use of Tablets Has Nearly Doubled Since 2011
    Physician use of tablet computers has nearly doubled since 2011, according to a new report by Manhattan Research, Becker's Hospital Review reports (Roney, Becker's Hospital Review, 5/14).
    ]]>     Tue, 15 May 2012 00:00:00 GMT     <![CDATA[Decision Resources Therapeutic Area Director Donny Wong, Ph.D. quoted in The Pink Sheet]]> Dalcetrapib Failure Raises Yet More Questions On Value Of Tinkering With HDL Cholesterol
    The termination of Roche 's dalcetrapib in a massive outcomes study raises more questions about not only the class of CETP inhibitors but also, once again, about the value of any therapy aimed at raising so-called "good" HDL cholesterol.
    ]]>     Mon, 14 May 2012 00:00:00 GMT     <![CDATA[Manhattan Research Analyst Maureen Malloy published in DTC Perspectives]]> Consumer Trends for a New Healthcare Reality
    Multiple trends are shaking up the consumer healthcare landscape – accelerating technology adoption, shifts in the traditional physician-patient relationship, new stakeholders coming to the forefront, evolving customer service expectations, among others. DTC marketers are struggling to keep up with these changes and understand what it means for their brands. This article discusses a few of the key trends that are shaping a new healthcare reality.
    ]]>     Wed, 09 May 2012 00:00:00 GMT     <![CDATA[Decision Resources Group to Convene Panel of Healthcare Experts at its Market Access Seminar in New York]]> Mon, 07 May 2012 16:40:47 GMT <![CDATA[Decision Resources Group to Convene Panel of Healthcare Experts at its Market Access Seminar in New York]]> Mon, 07 May 2012 16:40:47 GMT <![CDATA[Decision Resources Analyst Bingnan Kang, Ph.D., quoted in Nature Medicine]]> New biologic drugs get under the skin of psoriasis
    New results on the clinical efficacy of two experimental psoriasis medications are creating a buzz among those who study and treat the skin disease. The drugs—ixekizumab from Indiana-based Eli Lilly and brodalumab from California's Amgen—are the first to exclusively target an immune signaling molecule known as interleukin-17 (IL-17) and its receptor.
    ]]>     Fri, 04 May 2012 11:00:38 GMT     <![CDATA[Decision Resources data quoted in In Vivo]]> MS Boon: Many Drugs On The Way, But Will Payors Swallow The Cost?
    Two new oral drugs for relapsing remitting multiple sclerosis are poised for a near-term launch, and more drugs that work through different mechanisms of action could soon follow.
    ]]>     Wed, 02 May 2012 14:26:38 GMT     <![CDATA[Pharma Reps Can Now Access Formulary Data Anytime, Anywhere]]> ]]> Thu, 19 Apr 2012 09:13:35 GMT <![CDATA[Pharma Reps Can Now Access Formulary Data Anytime, Anywhere]]> ]]> Thu, 19 Apr 2012 09:13:35 GMT <![CDATA[Manhattan Research data quoted in iHealthBeat]]> How Many Times Per Month Do Certain Types of Patients Seek Online Health Information?
    U.S. adults with multiple sclerosis go online to look up health information about seven times per month, according to a survey by Manhattan Research.
    ]]>     Wed, 18 Apr 2012 16:53:06 GMT     <![CDATA[BioTrends Research Group Therapeutic Class Director Dan Winkelman quoted on Genomeweb]]> ALK Mutation Testing for NSCLC on the Rise among Oncologists, BioTrends Survey Finds
    A recent survey tracking the adoption of ALK mutation testing among oncologists suggests that doctors are becoming increasingly comfortable personalizing treatment strategies for non-small cell lung cancer patients based on clinical factors and genomic data.
    ]]>     Wed, 18 Apr 2012 15:04:13 GMT     <![CDATA[Decision Resources Analyst Kate Keeping quoted in FirstWord Pharma]]> Spotlight On: EMA accepts submission for first biosimilar antibody product
    The European Medicines Agency has published its list of new product applications, among which is a submission for biosimilar Remicade (infliximab), the branded version of which is marketed in Europe by Merck & Co.
    ]]>     Wed, 18 Apr 2012 14:57:24 GMT     <![CDATA[Decision Resources Group Acquires Pinsonault]]>
    Jim Lang Appointed President of the Market Access Business Unit
    ]]>     Tue, 17 Apr 2012 08:50:48 GMT     <![CDATA[Decision Resources Group Acquires Pinsonault]]>
    Jim Lang Appointed President of the Market Access Business Unit
    ]]>     Tue, 17 Apr 2012 08:50:48 GMT     <![CDATA[Decision Resources Group Associate Consultant Matthew Killeen, Ph.D. quoted in The Pink Sheet ]]> Janssen Looks To Differentiate Anticoagulant Xarelto With Broad Label
    Johnson & Johnson subsidiary Janssen Inc. believes that its oral anticoagulant Xarelto (rivaroxaban) is on its way to having the broadest label of any of the novel anticoagulant agents.
    ]]>     Thu, 12 Apr 2012 15:02:39 GMT     <![CDATA[Manhattan Research data quoted in MobiHealthNews]]> BlackBerry-maker RIM courts physicians with Bold
    The last time BlackBerry-maker Research In Motion (RIM) could convincingly claim to be the favorite device of doctors was probably May 2010.
    ]]>     Tue, 10 Apr 2012 15:52:29 GMT     <![CDATA[Decision Resources Group Associate Consultant Matthew Killeen, Ph.D. quoted in The Pink Sheet ]]> Janssen Plans New U.S. Filing For Xarelto, Based On Positive EINSTEIN-PE Results
    With the results from the EINSTEIN-PE non-inferiority trial, which showed a 50% reduction in major bleeding compared to the standard of care, Janssen Inc. is planning a second-quarter filing with FDA for its anti-coagulant Xarelto (rivaroxaban) in treatment and secondary prevention of symptomatic pulmonary embolism.
    ]]>     Wed, 28 Mar 2012 00:00:00 GMT     <![CDATA[Decision Resources Group Associate Consultant Matthew Killeen, Ph.D. quoted in The Pink Sheet ]]> Janssen Plans New U.S. Filing For Xarelto, Based On Positive EINSTEIN-PE Results
    With the results from the EINSTEIN-PE non-inferiority trial, which showed a 50% reduction in major bleeding compared to the standard of care, Janssen Inc. is planning a second-quarter filing with FDA for its anti-coagulant Xarelto (rivaroxaban) in treatment and secondary prevention of symptomatic pulmonary embolism.
    ]]>     Wed, 28 Mar 2012 00:00:00 GMT     <![CDATA[Decision Resources Analyst Lulu Pickering quoted on NJ.com]]> Princeton venture capital firm and Russians collaborate on life sciences
    Domain Associates is teaming up with the Russian government-backed investment group Rusnano in an ambitious deal to bring new medicines and medical devices to Russia’s emerging healthcare market.
    ]]>     Sun, 18 Mar 2012 11:00:38 GMT     <![CDATA[Decision Resources Analyst Anne-Elise Tobin, Ph.D. quoted on Bloomberg.com]]> Pain-Wracked Migraine Patients’ Unmet Needs Targeted by Map’s Inhaled Drug
    Companies led by Map Pharmaceuticals Inc. (MAPP) are pushing to develop better treatments for the 36 million Americans who get migraines. Regulators are set to announce this month if Map’s Levadex, an inhaled form of DHE that can be taken at home, can be marketed. If so, it may be worth $1 billion a year by 2020.
    ]]>     Tue, 06 Mar 2012 11:00:38 GMT     <![CDATA[Decision Resources Analyst Anne-Elise Tobin, Ph.D. quoted on Bloomberg.com]]> Pain-Wracked Migraine Patients’ Unmet Needs Targeted by Map’s Inhaled Drug
    Companies led by Map Pharmaceuticals Inc. (MAPP) are pushing to develop better treatments for the 36 million Americans who get migraines. Regulators are set to announce this month if Map’s Levadex, an inhaled form of DHE that can be taken at home, can be marketed. If so, it may be worth $1 billion a year by 2020.
    ]]>     Tue, 06 Mar 2012 11:00:38 GMT     <![CDATA[Decision Resources Analyst Christine Helliwell, Ph.D. quoted in The Pink Sheet ]]> Early Signs For Takeda’s TAK-875 Suggest The GPR40 Agonist Could Take On Other Oral Antidiabetics
    Full publication of Phase II results for Takeda Pharmaceutical Co. Ltd.’s diabetes drug TAK-875 – the most advanced GPR40 agonist – in the Lancet Feb. 27 suggests a profile potentially competitive with other new oral classes, such as DPP-4 and SGLT-2 inhibitors.
    ]]>     Thu, 01 Mar 2012 11:00:38 GMT     <![CDATA[Decision Resources Analyst Christine Helliwell, Ph.D. quoted in The Pink Sheet ]]> Early Signs For Takeda’s TAK-875 Suggest The GPR40 Agonist Could Take On Other Oral Antidiabetics
    Full publication of Phase II results for Takeda Pharmaceutical Co. Ltd.’s diabetes drug TAK-875 – the most advanced GPR40 agonist – in the Lancet Feb. 27 suggests a profile potentially competitive with other new oral classes, such as DPP-4 and SGLT-2 inhibitors.
    ]]>     Thu, 01 Mar 2012 11:00:38 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted in Medical Marketing & Media]]> MM&M Awards 2012: How to Win an Award
    The deadline for entries to the MM&M Awards (April 13) is fast approaching. To help give you an edge, we asked our 2011 judges to offer a few choice tips, based on their experiences of the review process.
    ]]>     Thu, 01 Mar 2012 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in Electronic Engineering Times]]> Bluetooth low energy enabled iPhone applications for mobile health
    Cambridge Consultants will demonstrate its latest Bluetooth low energy (BLE) iPhone 4S applications using CSR's BLE devices at this year's Mobile World Congress.
    ]]>     Sun, 26 Feb 2012 00:00:00 GMT     <![CDATA[HealthLeaders-InterStudy Analyst April Wortham quoted in The Commercial Appeal ]]> Heart groups see 'seamless' merger
    When Memphis Heart Clinic and Stern Cardiovascular Foundation complete their merger on March 1, all but one of the Heart Clinic's locations will remain and all of its employees will work for Stern, a company official said.
    ]]>     Thu, 23 Feb 2012 00:00:00 GMT     <![CDATA[HealthLeaders-InterStudy Analyst Deborah White quoted in The Post-Standard]]> Health care reform has hospitals jockeying to protect market share, grow more efficient
    Expect to see increased consolidations among area hospitals, more doctors leave private practice to become employees and health care reform pick up steam despite the controversy surrounding the federal health care reform law.
    ]]>     Tue, 21 Feb 2012 00:00:00 GMT     <![CDATA[Decision Resources Analyst Christine Helliwell, Ph.D. quoted in Boston Business Journal]]> Alkermes readies for diabetic treatment push
    CEO Richard Pops says Alkermes’ new Type 2 diabetes treatment has the potential to be an attractive choice for physicians and patients.
    ]]>     Fri, 10 Feb 2012 00:00:00 GMT     <![CDATA[Decision Resources Analyst Dr. Richa Mukherjee quoted on FirstWord Pharma]]> ViewPoints: FDA throws weight behind Kalydeco
    The FDA approval of Vertex’s cystic fibrosis (CF) therapy Kalydeco (ivacaftor) – over two months ahead of schedule – caught many by surprise. The decision both demonstrates decisiveness on the part of the regulator and a successful multi-faceted approach by Vertex to support approval.
    ]]>     Wed, 08 Feb 2012 00:00:00 GMT     <![CDATA[Decision Resources Analyst Michael Latwis quoted on FirstWord Pharma]]> Spotlight On: Pfizer's Lipitor strategy
    Will the post-expiry performance of Lipitor set a new trend?
    ]]>     Tue, 07 Feb 2012 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in Medical Marketing & Media]]> Patient Education: Vying for Attention
    Over the years, drugmakers have sought to raise awareness that attention-deficit hyperactivity disorder, a condition typically diagnosed in childhood, affects young and old alike. Their efforts have only been partially successful.
    ]]>     Wed, 01 Feb 2012 00:00:00 GMT     <![CDATA[Decision Resources Analyst Michael Latwis quoted on Barrons.com]]> Five Big Drugs for 2012
    These medications could boost the fortunes of companies like Pfizer, Gilead Sciences and Bristol-Myers Squibb.
    ]]>     Wed, 25 Jan 2012 00:00:00 GMT     <![CDATA[Decision Resources Group to Bring its One-Day Oncology Seminar to San Francisco ]]> Mon, 23 Jan 2012 11:39:18 GMT <![CDATA[Decision Resources Group to Bring its One-Day Oncology Seminar to San Francisco ]]> Mon, 23 Jan 2012 11:39:18 GMT <![CDATA[Manhattan Research data quoted in The Wall Street Journal]]> Should Physicians Use Email to Communicate With Patients?
    Email has been so commonplace for so long that some people consider it nearly obsolete. But in the health-care profession, its use for communications between doctors and their patients is still controversial.
    ]]>     Mon, 23 Jan 2012 00:00:00 GMT     <![CDATA[Manhattan Research data quoted on MobiHealthNews]]> Each month 16.9M access health info via mobiles
    According to a new report from comScore, the number of people in the US who access health information from their mobile devices is on the rise.
    ]]>     Mon, 16 Jan 2012 00:00:00 GMT     <![CDATA[Decision Resources Analyst Alana Simorellis, Ph.D. quoted in Behavioral Healthcare]]> Three key antipsychotics lose patent protection
    State Medicaid programs, patients to save as major atypical meds “go generic”
    ]]>     Thu, 22 Dec 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in PharmaTimes]]> Europeans prefer info from drugmakers direct, not on Twitter
    As pharma increasingly explores ways of using social media, a survey carried out in Europe suggests that people looking for information about drugmakers and their products are not so enthusiastic.
    ]]>     Tue, 06 Dec 2011 00:00:00 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted in Medical Marketing & Media]]> Leadership Exchange: Multichannel Marketing
    Choosing your channels and creating an effective integrated campaign is no easy task. Luckily, a panel of experts is here to help.
    ]]>     Thu, 01 Dec 2011 00:00:00 GMT     <![CDATA[Millennium Research Group Analyst Sohaib Perwaiz quoted in Clinica ]]> Pelvic floor recon market to shrink by over 15% on safety concerns
    The pelvic floor reconstruction market, comprising devices such as the transvaginal meshes which were at the centre of a safety storm this year, will see sales decrease by over 15% this year, according to the Millennium Research Group. The organisation valued the market at around $115m in 2011.
    ]]>     Wed, 09 Nov 2011 00:00:00 GMT     <![CDATA[Millennium Research Group Analyst Sohaib Perwaiz quoted in Clinica ]]> Pelvic floor recon market to shrink by over 15% on safety concerns
    The pelvic floor reconstruction market, comprising devices such as the transvaginal meshes which were at the centre of a safety storm this year, will see sales decrease by over 15% this year, according to the Millennium Research Group. The organisation valued the market at around $115m in 2011.
    ]]>     Wed, 09 Nov 2011 00:00:00 GMT     <![CDATA[Decision Resources Analyst Matthew Killeen, Ph.D. quoted in Cardiology News and Health News Daily]]> Dabigatran's First A Fib Year Starts Warfarin's Decline
    For decades, physicians and patients bemoaned the problems and inconveniences of warfarin to prevent strokes caused by atrial fibrillation. A simpler, easier oral anticoagulant was what people wanted and what drove drug companies to try to find alternatives.
    ]]>     Tue, 08 Nov 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted on MobiHealthNews]]> BlackBerry lauded for enabling disaster recovery efforts
    Research In Motion (RIM) is this year’s recipient of the International Medical Corps’ Global Impact award for aiding disaster-recovery efforts worldwide with its BlackBerry smartphone. The 2011 Annual Awards Celebration takes place in Los Angeles next week.
    ]]>     Mon, 07 Nov 2011 00:00:00 GMT     <![CDATA[Decision Resources Analyst Jonathan Searles quoted in Nature Medicine]]> MS pipeline flowing, but niche remains for neuroprotection
    For decades, people with multiple sclerosis have injected themselves daily with immunosuppressant drugs for lack of a better option, in hopes of mitigating the disease's neurodegenerative effects. But newly designed oral therapies for the disorder have proliferated over the past few years, foretelling a future with fewer pricks.
    ]]>     Mon, 07 Nov 2011 00:00:00 GMT     <![CDATA[HealthLeaders-InterStudy Analyst Paula Wade quoted on TheDeal.com]]> HealthSpring deal shows commercial appeal of ACOs
    Cigna Corp.'s proposed $3.8 billion purchase of HealthSpring Inc. is an endorsement of Washington's plan to promote accountable care organizations as a way to both cut health expenditures and improve quality of care.
    ]]>     Fri, 04 Nov 2011 00:00:00 GMT     <![CDATA[HealthLeaders-InterStudy Analyst Paula Wade quoted on TheDeal.com]]> HealthSpring deal shows commercial appeal of ACOs
    Cigna Corp.'s proposed $3.8 billion purchase of HealthSpring Inc. is an endorsement of Washington's plan to promote accountable care organizations as a way to both cut health expenditures and improve quality of care.
    ]]>     Fri, 04 Nov 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in MobiHealthNews]]> 75 percent of nurses own smartphones or tablets
    According to a new study conducted by textbook publisher Springer Publishing, 74.6 percent of nurses in the US use smartphones or tablets. Of those smartphone owners, 43.7 percent own an iPhone or iPod Touch, 29.8 percent an Android phone, and 22 percent an iPad.
    ]]>     Tue, 01 Nov 2011 00:00:00 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted in American Medical News]]> Many patients taking a pass on electronic access to records
    Some physicians, however, say there are ways to pique interest in looking at health information.
    ]]>     Mon, 31 Oct 2011 00:00:00 GMT     <![CDATA[Decision Resources Analyst Prachi Vora quoted in New Jersey Star Ledger]]> BioReference's genetic-testing business has new tool for detecting rare diseases
    Scientists at GeneDx, a subsidiary of Elmwood Park-based BioReference Labs, develop a new genetic test capable of analyzing a patient’s DNA more comprehensively than existing technology.
    ]]>     Tue, 25 Oct 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted on iHealthBeat]]> How Many People Have Accessed or Would Like To Access Health Data on a Doctor-Hosted EHR?
    Fifty-six million U.S. consumers already have accessed their medical information on an electronic health record system maintained by their physician, according to a Manhattan Research survey.
    ]]>     Wed, 19 Oct 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in Information Week]]> Apple FaceTime May Be HIPAA Secure
    Use of tablets and smartphones for secure communications could produce a major change in the way doctors and patients communicate--if reimbursement policies change.
    ]]>     Wed, 12 Oct 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in The Economist]]> The consumer-industrial complex
    All sorts of organisations are borrowing ideas from consumer technology
    ]]>     Sat, 08 Oct 2011 00:00:00 GMT     <![CDATA[Decision Resources Analyst Kate Sullivan quoted on Fox Business News]]> The Widening of the Obese Market: Companies Cash In on Growing Waistlines
    Nearly 150 million people in the U.S. are obese or overweight, according to market research statistics. With little evidence of this demographic slimming down, experts say the obesity market is rife with opportunities for businesses to cash in.
    ]]>     Fri, 07 Oct 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in eWeek]]> With iPhone, iPad Apple's Steve Jobs Changed Course of Health Care
    With Steve Jobs at the helm, Apple developed the iPhone and iPad, creating a way for doctors to monitor patients remotely, e-prescribe medication and hold telehealth sessions.
    ]]>     Fri, 07 Oct 2011 00:00:00 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted on Eye For Pharma]]> Pharma sales: Focus on the mobile opportunity
    The raw data speaks to the growing prevalence of online and mobile health. In the US, more than 80 percent of Americans search online for health information, according to the Pew Internet & American Life Project.
    ]]>     Wed, 05 Oct 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in ClickZ]]> Love and Other Drugs, Reloaded
    From 2000 to 2006, the number of drug reps in the U.S. reached 100,000. However, as pipelines dried up and the rules around marketing of drugs got stricter, the drug companies started laying off reps and started looking for alternate ways to educate the doctors and promote their products.
    ]]>     Mon, 03 Oct 2011 00:00:00 GMT     <![CDATA[Decision Resources Analyst Natalie Taylor, Ph.D. quoted on Reuters.com]]> Targacept depression drug: high risk, high reward
    Targacept Inc, a small drugmaker that began life inside the bowels of R.J. Reynolds Tobacco Co, has for years been using its understanding of nicotine to develop experimental treatments for depression, schizophrenia and smoking cessation.
    ]]>     Mon, 03 Oct 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in FierceMobileHealthcare]]> Apple changes mHealth game with HIPAA security claims
    Apple's claim that FaceTime video chat can be made HIPAA-compliant could be a game-changer for telemedicine specifically and healthcare generally.
    ]]>     Mon, 03 Oct 2011 00:00:00 GMT     <![CDATA[Decision Resources Director Dr. Andrew Merron quoted in PharmaTimes]]> What’s new copycat?
    Blockbuster biologics aren’t immune to patent expiries and a raft of companies are ready to pounce with copycat versions. But biosimilars aren’t generics – they have their own unique set of problems
    ]]>     Fri, 30 Sep 2011 12:01:57 GMT     <![CDATA[Decision Resources data quoted on Fox Business News]]> Novartis To File Lung Drug In Europe After Strong Trials
    Novartis AG (NVS) on Tuesday said it will file experimental lung medicine NVA237 with European regulators in the wake of strong trial data, raising the odds that its lung-drug franchise will develop into a multi-billion-dollar business.
    ]]>     Tue, 27 Sep 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in iHealthBeat]]> The Two-Way Street of Patient Engagement in Health IT
    In 2005, President George W. Bush channeled Harry Truman's "chicken in every pot" moment saying that "within 10 years, every American must have a personal electronic medical record." That vision is coming into view under President Obama. HHS has undertaken a major push to get U.S. citizens to understand the concept and value of electronic health records.
    ]]>     Tue, 27 Sep 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in American Medical News]]> Nearly all U.S. doctors are now on social media
    Although most are active on sites personally -- and many professionally -- they have been reluctant to engage with patients.
    ]]>     Mon, 26 Sep 2011 00:00:00 GMT     <![CDATA[Decision Resources data quoted on Reuters.com]]> Analysis: New drugs drive prostate cancer market
    Options for treating prostate cancer are expanding with the advent of novel, and more expensive, medicines, with key data expected soon for what could be one of the biggest new drugs.
    ]]>     Mon, 19 Sep 2011 00:00:00 GMT     <![CDATA[HealthLeaders-InterStudy Analyst Joel Peyton quoted in Crain’s Chicago Business Journal]]> Blue Cross parent's profits drop in second quarter
    After surging earlier in the year, profits of the parent of Blue Cross & Blue Shield of Illinois dropped sharply during the second quarter, to a still hefty $270 million, as benefits rose and membership shrank.
    ]]>     Mon, 19 Sep 2011 00:00:00 GMT     <![CDATA[Decision Resources Group Analysts Will Examine Oncology Market Drivers, Hurdles and Opportunities at Boston Seminar]]> ]]> Wed, 07 Sep 2011 08:52:04 GMT <![CDATA[Decision Resources Group Analysts Will Examine Oncology Market Drivers, Hurdles and Opportunities at Boston Seminar]]> ]]> Wed, 07 Sep 2011 08:52:04 GMT <![CDATA[Decision Resources data quoted in FiercePharma]]> J&J's prostate drug Zytiga gets final nod in Europe
    Another new prostate cancer drug will soon hit the market in Europe. Regulators there approved Johnson & Johnson's Zytiga pill as a second-line treatment, after a fast-track review.
    ]]>     Wed, 07 Sep 2011 00:00:00 GMT     <![CDATA[Decision Resources data quoted in FiercePharma]]> J&J's prostate drug Zytiga gets final nod in Europe
    Another new prostate cancer drug will soon hit the market in Europe. Regulators there approved Johnson & Johnson's Zytiga pill as a second-line treatment, after a fast-track review.
    ]]>     Wed, 07 Sep 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in Times-News of Twin Falls, Idaho]]> There's an App for that Cold
    As a physician, it’s not uncommon for Dr. Trevor Satterfield to meet with patients who can remember what a pill looks like, but the name escapes them. That’s where his iPhone has become his best friend.
    ]]>     Sat, 20 Aug 2011 00:00:00 GMT     <![CDATA[Decision Resources Analyst Natalie Taylor, Ph.D. quoted in The Pink Sheet]]> MDD Market Snapshot: Depressing Future For Antidepressants
    Although a significant portion of the U.S. population, approximately 6.5% or 15 million adults annually suffers from depression, the antidepressant drug market is on the decline and sales are expected to decrease further over the next two years as two of the largest products on the market face patent expirations.
    ]]>     Fri, 19 Aug 2011 00:00:00 GMT     <![CDATA[Decision Resources Analyst Graeme Green, Ph.D. quoted on Bloomberg.com]]> Roche Seeks Win on Heart Pill Where Pfizer Failed
    Roche Holding AG (ROG) may get the first signs at a cardiology conference this month that the Swiss drugmaker can garner $6.8 billion in sales with a pill to combat heart disease by raising so-called good cholesterol.
    ]]>     Fri, 19 Aug 2011 00:00:00 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted on ClickZ.com]]> For Pharma, FDA Is Elephant in Facebook Comment Room
    On Monday, Facebook began requiring pharmaceutical brand pages to enable comments, as expected. Yet, although pharma marketers are fearful of regulatory reaction to a potential flood of comments, some don't see Facebook as the big villain in the story. It's the Food and Drug Administration that's raised the most ire.
    ]]>     Wed, 17 Aug 2011 00:00:00 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted in The Wall Street Journal Health Blog]]> Pharma-Page Facebook Commenters, Start Your Engines
    Social media can be a minefield for pharma companies given the FDA’s requirements to keep product information fairly balanced and promote only approved uses of drugs.
    ]]>     Mon, 15 Aug 2011 00:00:00 GMT     <![CDATA[Decision Resources Analyst Rachel Webster, D. Phil. quoted in The Pink Sheet]]> Disappointing Provenge Sales Stir Doubts About Demand
    Dendreon Corp. withdrew its yearly sales forecast for the new prostate cancer immunotherapy Provenge on August 3, shocking Wall Street, and raising concerns about whether the high-profile company had hit a speed bump - or mountain.
    ]]>     Wed, 10 Aug 2011 00:00:00 GMT     <![CDATA[Decision Resources Therapeutic Area Director Donny Wong, Ph.D. and BioTrends Director Andrew Merron, Ph.D. quoted in The Pink Sheet]]> Biosimilar Insulin Worth The Effort? For Some, Maybe
    With most eyes fixed on the imminent arrival of biosimilar antibodies – billed as the most valuable copy-cat biologics, given originators' high prices – it may be easy to overlook the potential of first-generation biosimilars such as insulin.
    ]]>     Tue, 26 Jul 2011 00:00:00 GMT     <![CDATA[Decision Resources Analysts Janie Cox, Ben Duncan and Neil Grubert quoted in PharmaTimes]]> Life after the small molecule
    Since 2006 the growth of biologics has outstripped small molecules, and this trend is set to continue. So is the biologic the latest silver bullet? Or are the associated costs enough for pharma to put on the brakes?
    ]]>     Tue, 26 Jul 2011 00:00:00 GMT     <![CDATA[Decision Resources Group Acquires PharmaStrat]]>
    Company’s Name Change to Decision Resources Group to Better Reflect Organic and Acquisition Growth Strategy
    ]]>     Mon, 25 Jul 2011 10:01:25 GMT     <![CDATA[Decision Resources Group Acquires PharmaStrat]]>
    Company’s Name Change to Decision Resources Group to Better Reflect Organic and Acquisition Growth Strategy
    ]]>     Mon, 25 Jul 2011 10:01:25 GMT     <![CDATA[Manhattan Research data quoted in eWeek]]> Cisco Cius Android Tablets Go to Work on San Diego Hospital Private Cloud
    In advance of the July 31 launch of the Cisco Cius enterprise Android tablet, Palomar Pomerado Health System in San Diego has deployed the Cius in a pilot trial to enable doctors to access mobile health applications from a private cloud.
    ]]>     Fri, 22 Jul 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in Mobi Health News]]> iPad EHR developer DrChrono secures $675K
    DrChrono, one of the few electronic health records (EHR) vendors to offer an EHR built from the ground up for the Apple iPad, has raised $675,000 in seed funding, according to a report in TechCrunch.
    ]]>     Thu, 14 Jul 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted on CBS 21 News]]> Are Americans becoming cyberchondriacs?
    When it comes to getting sick, many of us want answers right away. So it's no wonder why statistics show more people are logging on to get them.
    ]]>     Wed, 13 Jul 2011 00:00:00 GMT     <![CDATA[Decision Resources Analyst Matthew Killeen, Ph.D. quoted in The Pink Sheet]]> FDA Approval Of Xarelto Bodes Well For Drug's Future Expansion
    The July 1 approval of Johnson & Johnson 's novel anticoagulant Xarelto for prevention of deep vein thrombosis is an important step for J&J and its ex-U.S. partner Bayer AG as they gear up to play in the highly promising but increasingly complicated world of novel anticoagulants.
    ]]>     Tue, 12 Jul 2011 12:01:57 GMT     <![CDATA[Manhattan Research data quoted on Seacoastonline.com]]> House Detective: Self-diagnosing on the Web can be bad for your health
    Statistics show "cyberchondria" is a burgeoning phenomenon. Seventy-two percent of U.S. adult internet users searched health-related information in 2010, compared to 63 million in 2002. The Harris Poll puts 2010 numbers at 175 million Americans, up from 154 million the previous year. And the Pew Institute says health issues are the third most popular online activity. Point: on the rise
    ]]>     Thu, 30 Jun 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in The Herald]]> May local efforts inspire more
    Let's take back technological advances that have been sullied by tawdry tweets.
    ]]>     Thu, 30 Jun 2011 00:00:00 GMT     <![CDATA[Decision Resources data quoted in The Wall Street Journal]]> Enlisting the Body to Fight Cancer
    Scientists are scrambling to develop medications that fight cancer by spurring the body's immune system, a form of treatment that some cancer specialists believe may hold the key to keeping a patient permanently disease-free.
    ]]>     Tue, 14 Jun 2011 00:00:00 GMT     <![CDATA[Decision Resources data quoted in The Wall Street Journal]]> ]]> Tue, 14 Jun 2011 00:00:00 GMT <![CDATA[Manhattan Research data quoted in American Medical News]]> Apps let patients view insurance on smartphones
    Health plans hope access will better connect members, doctors and insurers and reduce costs. Apps for physicians are coming.
    ]]>     Mon, 13 Jun 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in HealthLeaders Media]]> EMR in Your Pocket
    There’s no doubt smartphones are popular, and they are particularly beloved by physicians. But healthcare leaders need to consider how the practical value of such devices will benefit the entire organization—not just individual docs.
    ]]>     Mon, 13 Jun 2011 00:00:00 GMT     <![CDATA[Manhattan Research Vice President Monica Levy quoted in iHealthBeat]]> FDA Taking Closer Look at Regulation of Health-Related Mobile Apps
    An FDA spokesperson recently said the agency intends to provide "greater regulatory clarity" on health-related mobile applications, as the technology becomes more popular and sophisticated, InformationWeek reports.
    ]]>     Wed, 08 Jun 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in iHealthBeat]]> 360 Degrees of Health: The Limitations of Mobile Apps
    The market for mobile health is one of the brightest lights of the economy, based on forecasts published during the first half of 2011. In-Stat expects that the market for wireless health will reach $4.5 billion in 2014. Meanwhile, McKinsey gauges the "global mHealth opportunity" at $50 billion.
    ]]>     Tue, 07 Jun 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in The Charlotte Observer]]> Docs add apps to their medical bag
    As Dr. John Allbert watched his teenage daughter's spring talent show, his cellphone began vibrating. He stepped outside to take the call from a fellow obstetrician wanting advice about a pregnant patient whose fetus might be in distress. To get a better picture of the situation, Allbert walked to his car to grab his iPad. There on the 8- by 10-inch screen, Allbert read the patient's vital signs and saw the squiggly lines that represented the baby's heartbeat and the mother's contractions.
    ]]>     Mon, 06 Jun 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in iHealthBeat]]> Of Doctors Online for Professional Purposes, What Percentage Agree Internet Is Essential?
    Among those who are online for professional reasons, 92% of physicians in Russia and 85% of U.S. physicians agree that the Internet is essential to their professional practice, according to a Manhattan Research report.
    ]]>     Fri, 03 Jun 2011 00:00:00 GMT     <![CDATA[Wolters Kluwer Pharma Solutions and Decision Resources Inc. to Provide Easy Access to Managed Markets Data]]> ]]> Thu, 02 Jun 2011 08:58:36 GMT <![CDATA[Wolters Kluwer Pharma Solutions and Decision Resources Inc. to Provide Easy Access to Managed Markets Data]]> ]]> Thu, 02 Jun 2011 08:58:36 GMT <![CDATA[Manhattan Research Vice President Monica Levy quoted in Healthcare IT News]]> Docs in 'less mature' clinical content markets turn to social media
    Physicians in the BRIC region – Russia and India in particular – are incorporating social networks and online communities into their professional resource mix. This trend is likely due in part to user-generated content from peers filling a gap in the availability of online clinical resources in some of these high growth pharma markets, according to a new study from Manhattan Research.
    ]]>     Tue, 31 May 2011 00:00:00 GMT     <![CDATA[Manhattan Research Vice President Monica Levy quoted in American Medical News]]> FDA signals it will regulate medical apps
    As more medical mobile applications get developed, one thorny question has arisen: Is there anyone who should be verifying whether these apps are effective and safe?
    ]]>     Mon, 30 May 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted on Bloomberg.com]]> As Doctors Limit Access, Pharma Taps Viscira for Simulations
    Viscira specializes in technology-enabled collateral for pharmaceutical marketers trying to reach doctors. Best known for its computer animations, Viscira produces a slew of products, from applications for mobile devices to continuing education presentations, says Chief Executive Officer Dave Gulezian, 43. The common thread: “scientific accuracy and visual effects that tell a story in an impactful way.”
    ]]>     Fri, 27 May 2011 11:13:00 GMT     <![CDATA[Decision Resources Analyst Ramya Kollipara, Ph.D. quoted on Bloomberg.com]]> Roche Leads Deadly Skin Cancer Turnaround to ‘Golden Age’ of Drug Research
    The drug vemurafenib, from Swiss drugmaker Roche Holding AG (ROG) and Daiichi Sankyo Co. of Tokyo, is part of a revolution in cancer biology. Metastatic melanoma has long been a death sentence, killing 8,700 Americans a year. Now medicines from Roche, Daiichi, Bristol-Myers Squibb Co. (BMY) and GlaxoSmithkline Plc (GSK) are among a dozen in advanced testing that are starting to rewrite the prognosis for patients with this disease.
    ]]>     Wed, 25 May 2011 12:01:57 GMT     <![CDATA[Decision Resources Analyst Seamus Levine-Wilkinson quoted in New Jersey Star Ledger]]> Merck gets to finish line first with new anti-viral drug for Hepatitis C
    On Friday, Merck won approval from federal regulators to begin marketing Victrelis, its new anti-viral drug for hepatitis C, beating out Massachusetts-based Vertex Pharmaceuticals to push out the first new treatment for the virus in a decade.
    ]]>     Sat, 14 May 2011 18:30:21 GMT     <![CDATA[Manhattan Research Analyst James Avallone quoted in iHealthBeat]]> What Percentage of Surveyed Physicians in the U.S. Have Adopted Smart Phones?
    Eighty-one percent of surveyed U.S. physicians say they have adopted smart phones, according to a new Manhattan Research survey.
    ]]>     Wed, 11 May 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in The Miami Herald]]> For busy doctors, apps are the cure
    When Dr. Jose Soler got a late-night call about a critically ill patient, he grabbed his iPad and checked the results of the electrocardiogram test that just had been administered. Thanks to an app that zooms within half a millimeter of every heartbeat rhythm variation, Soler made a diagnosis within two minutes.
    ]]>     Mon, 09 May 2011 00:00:00 GMT     <![CDATA[Manhattan Research President Meredith Ressi and Senior Analyst James Avallone quoted in eWeek]]> 75 Percent of Physicians Prefer Apple iPad, iPhone: Survey
    With the rapid growth of mobile devices in health care, 75 percent of doctors in the United States own some form of Apple device (iPhone, iPad, or iPod), according to a new study by Manhattan Research.
    ]]>     Fri, 06 May 2011 00:00:00 GMT     <![CDATA[Decision Resources, Inc.’s Competitive Landscape Seminar Series: Biologics and Biosimilars Will Provide Pharmaceutical Industry Executives with Actionable Insights on Biologics and Biosimilars Market ]]> ]]> Wed, 04 May 2011 10:00:20 GMT <![CDATA[Decision Resources, Inc.’s Competitive Landscape Seminar Series: Biologics and Biosimilars Will Provide Pharmaceutical Industry Executives with Actionable Insights on Biologics and Biosimilars Market ]]> ]]> Wed, 04 May 2011 10:00:20 GMT <![CDATA[Manhattan Research President Meredith Ressi quoted in Medical Marketing & Media]]> Mobile mania: smartphone users dialing up health info; docs prefer Apple
    Another day, another batch of survey data showing that smartphones have become the tail wagging the dog in medical media.
    ]]>     Wed, 04 May 2011 00:00:00 GMT     <![CDATA[Decision Resources Director Andrew Merron quoted in PharmaTimes]]> Non-Hodgkin's lymphoma drug market "will more than double" by 2019
    Sales of drugs to treat non-Hodgkin's lymphoma are set to more than double in value over the next decade, increasing in seven major world markets from around $4 billion in 2009 to $8.4 billion by 2019, according to new forecasts.
    ]]>     Wed, 04 May 2011 00:00:00 GMT     <![CDATA[Decision Resources, Inc. CEO Peter Hoenigsberg quoted in Boston Business Journal]]> The drug evaluators
    As health care costs skyrocket and the federal health overhaul expands the number of patients newly covered by insurance, the federal government and private insurers are increasingly demanding to know which drugs and medical devices work best.
    ]]>     Fri, 29 Apr 2011 00:00:00 GMT     <![CDATA[Decision Resources, Inc. CEO Peter Hoenigsberg quoted in Boston Business Journal]]> The drug evaluators
    As health care costs skyrocket and the federal health overhaul expands the number of patients newly covered by insurance, the federal government and private insurers are increasingly demanding to know which drugs and medical devices work best. Massachusetts is shaping up to be a hotbed of so-called comparative effectiveness research, which seeks to answer those questions.
    ]]>     Fri, 29 Apr 2011 00:00:00 GMT     <![CDATA[Decision Resources Therapeutic Area Director Donny Wong, Ph.D. quoted in New Jersey Star Ledger ]]> Novo Nordisk strives to find a drug to combat obesity
    Novo Nordisk, undaunted by the pharmaceutical industry’s recent failures in the field, is pushing ahead on the development of a new drug to treat obesity as part of its effort to fight diabetes.
    ]]>     Sun, 17 Apr 2011 00:00:00 GMT     <![CDATA[Decision Resources Analyst Matthew Killeen, Ph.D. quoted on The Pink Sheet ]]> Bayer/J&J Attempt At New Lands For Xarelto Backfires With MAGELLAN
    A trial designed to expand the market for Bayer HealthCare/Johnson & Johnson's oral anticoagulant Xarelto (rivaroxaban) instead has highlighted that the drug has a worse bleeding profile than Sanofi-Aventis' low molecular weight heparin Lovenox (enoxparin) in patients hospitalized with acute illnesses.
    ]]>     Fri, 08 Apr 2011 10:20:57 GMT     <![CDATA[HealthLeaders-InterStudy Analyst Paula Wade quoted in The Virginian Pilot ]]> Report: 2 firms dominate Hampton Roads' insurance market
    Two companies dominate commercial health insurance in Hampton Roads, according to a recent report from the American Medical Association.
    ]]>     Mon, 28 Mar 2011 00:00:00 GMT     <![CDATA[Decision Resources Director Nikhil Mehta quoted on The Pink Sheet]]> Amarin Version 3.0 Weighs Its Options on Promising Omega-3 Pipeline
    Feisty Amarin is certainly undergoing a reincarnation. 
    ]]>     Fri, 18 Mar 2011 00:00:00 GMT     <![CDATA[Manhattan Research article by Senior Healthcare Analyst Maureen Malloy and Senior Digital Healthcare Analyst James Avallone on pharmaphorum.com]]> Key European consumer and physician eHealth trends for 2011
    The Internet has drastically changed how both consumers and physicians gather medical information and consume media.
    ]]>     Thu, 17 Mar 2011 11:10:34 GMT     <![CDATA[Manhattan Research article by President Meredith Ressi in Med Ad News ]]> What’s in Store for Pharma Marketing in the Year Ahead?
    Looking toward the year ahead, a few themes are common across pharma companies and agencies large and small.
    ]]>     Thu, 17 Mar 2011 11:10:34 GMT     <![CDATA[Decision Resources Analyst Courtney Stanton, Ph.D. quoted on Bloomberg.com]]> HIV Drug Development Falters as Merck, Bristol-Myers Struggle With Success
    Gilead Sciences Inc., the world’s biggest AIDS-drug maker, revolutionized treatment and helped forge a $15 billion market with a single daily pill attacking the virus with three medicines at once.]]>     Mon, 14 Mar 2011 09:36:21 GMT     <![CDATA[Decision Resources Analyst Courtney Stanton, Ph.D. quoted on Bloomberg.com]]> HIV Drug Development Falters as Merck, Bristol-Myers Struggle With Success
    Gilead Sciences Inc., the world’s biggest AIDS-drug maker, revolutionized treatment and helped forge a $15 billion market with a single daily pill attacking the virus with three medicines at once.
    ]]>     Mon, 14 Mar 2011 09:36:21 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted on washingtonpost.com]]> USA Mobility jumping from pagers to smartphones, tablets with acquisition of Amcom
    Springfield-based USA Mobility saw its subscribers dwindle from 6 million in 2004 to 1.9 million at the end of last year as the expansion of text messaging and smartphone use continued to rattle its paging business. In many ways, it was a living relic of a bygone era in telecommunications.
    ]]>     Sun, 13 Mar 2011 01:00:00 GMT     <![CDATA[Manhattan Research Vice President Monique Levy quoted in Medical Marketing & Media ]]> Website Development: Build it Right and They Will Come
    The number of adult consumers seeking pharma information online has more than doubled since 2005, up from 55 million to 112 million last year according to Manhattan Research's 2010 ePharma Consumer v10.0 study. Not surprisingly, pharma spend in digital channels has also increased.
    ]]>     Fri, 11 Mar 2011 01:00:00 GMT     <![CDATA[Fingertip Formulary data quoted on The Pink Sheet ]]> With Pradaxa On The Rise, Medco Gathers Evidence On Warfarin Diagnostic Testing
    Pharmacy benefits management company Medco Health Solutions Inc. says that with the newly approved oral anticoagulant Pradaxa (dabigatran) off to a good commercial start, it plans to monitor outcomes and compare results with generic warfarin that has been optimized according to genetic testing.
    ]]>     Thu, 10 Mar 2011 11:10:34 GMT     <![CDATA[Decision Resources Pharmaview Analyst Michael Latwis quoted in Chemical & Engineering News]]> Daiichi Will Buy Plexxikon
    Pharmaceuticals: Deal adds to spending spree by Japan’s drugmakers
    ]]>     Mon, 07 Mar 2011 13:38:20 GMT     <![CDATA[Manhattan Research data quoted on MercuryNews.com ]]> PAMF doctors give patients a break: Free e-messaging
    It used to cost $60 a year to have an online conversation with doctors affiliated with the Palo Alto Medical Foundation. Now the service is free.
    ]]>     Tue, 01 Mar 2011 11:10:34 GMT     <![CDATA[Millennium Research Group data quoted in DotMed News ]]> One-fifth of U.S. hospitals plan to replace their PACS
    One-fifth of U.S. hospitals plan to replace their picture archiving and communications systems, and nearly half have radiology systems more than five years old, according to a new market survey.
    ]]>     Mon, 28 Feb 2011 00:00:00 GMT     <![CDATA[HealthLeaders-InterStudy Analyst Josh Kelley quoted in The St. Petersburg Times ]]> ]]> Mon, 21 Feb 2011 00:00:00 GMT <![CDATA[Millennium Research Group Analyst Basim Mansour was quoted in DotMed News]]> "Meaningful use" spells trouble for PACS market
    The radiology industry should brace for a significant dip in sales and market size for picture archiving and communication systems, radiology information systems, and cardiovascular information systems as the 2009 American Recovery and Reinvestment Act continues to shift hospital IT budgets away from these traditional software tools and toward the use of electronic health records, according to a new report.
    ]]>     Thu, 17 Feb 2011 12:18:11 GMT     <![CDATA[Decision Resources Analyst Sami Fam, Ph.D. quoted in Palm Beach Post]]> Scripps Florida breakthrough blocks Parkinson's
    Scientists at Scripps Florida have discovered a way to stop the progress of Parkinson's disease, the brain disorder that afflicts about 1 million Americans and has defied the search for a cure.
    ]]>     Fri, 11 Feb 2011 09:36:21 GMT     <![CDATA[Millennium Research Group Senior Analysts Deanna Vankessel and Melissa Hussey quoted in Becker's ASC Review ]]> 7 Critical Orthopedic and Spine Device Industry Trends
    The orthopedic and spine device market is a constantly changing dynamic field and companies at need to stay at the cutting-edge of surgical technique and development to market the most successful products.
    ]]>     Thu, 10 Feb 2011 09:44:13 GMT     <![CDATA[Millennium Research Group Principal Analyst Karene Dumoulin was quoted on Medical Device Daily]]> MRG analyst offers insight into BSX-Atritech deal
    Last week Boston Scientific (Natick, Massachusetts) added Atritech (Plymouth, Minnesota) to its shopping list, announcing its intention to acquire the company for $100 million upfront plus potential payments of up to $275 million. The deal gives Boston Scientific a device backed by strong clinical evidence and puts the company in an ideal position in the endocardio left atrial appendage (LAA) market, according to Karene Dumoulin, principal analyst of cardiovascular at Millennium Research Group (MRG; New York).
    ]]>     Fri, 28 Jan 2011 00:00:00 GMT     <![CDATA[Millennium Research Group Principal Analyst Karene Dumoulin was quoted on Bloomberg.com]]> Abbott's Neck Stent Met Primary Goals in Study, FDA Staff Says in Report
    Abbott Laboratories’s carotid stent met primary study goals for wider use, according to U.S. regulators weighing whether to expand the device’s approved use beyond patients who are too sick for surgery. 
    ]]>     Mon, 24 Jan 2011 00:00:00 GMT     <![CDATA[Millennium Research Group Principal Analyst Karene Dumoulin was quoted on Bloomberg.com]]> Abbott's Neck Stent Met Primary Goals in Study, FDA Staff Says in Report
    Abbott Laboratories’s carotid stent met primary study goals for wider use, according to U.S. regulators weighing whether to expand the device’s approved use beyond patients who are too sick for surgery. 
    ]]>     Mon, 24 Jan 2011 00:00:00 GMT     <![CDATA[Millennium Research Group data quoted in Becker's ASC Review ]]> 6 Predictions on Device Market Growth in the Next Five Years
    Here are six predictions on the growth of device and equipment markets over the next five years, according to various reports and studies.
    ]]>     Fri, 21 Jan 2011 11:06:18 GMT     <![CDATA[HealthLeaders-InterStudy Analyst Deborah White quoted in AMN’s Healthcare Briefings]]> Growing Hospitals the Old-fashioned Way: Mergers and Acquisitions
    It happens all the time in business – mergers and acquisitions to achieve growth, improve the value of a company and ensure the future.  Up until a few years ago, growth by merger or acquisition wasn’t really a strategy in the healthcare sector.  It is now.
    ]]>     Wed, 19 Jan 2011 11:45:52 GMT     <![CDATA[Millennium Research Group data was quoted in The Minneapolis Star Tribune ]]> Bulging market for aortic stents
    Medtronic is among a number of companies with new products for a type of aneurysm that can be deadly if it bursts.
    ]]>     Sun, 16 Jan 2011 10:27:55 GMT     <![CDATA[Manhattan Research data quoted on iHealthBeat web site]]> How Many U.S. Adults Use Social Media Resources for Health-Related Purposes?
    In 2010, 89 million U.S. adults tapped social media resources for health-related purposes, compared with 63 million in 2008 and 38 million in 2007, according to a Manhattan Research study.
    ]]>     Thu, 13 Jan 2011 11:10:34 GMT     <![CDATA[Decision Resources Director Donny Wong, Ph.D. quoted on The Pink Sheet ]]> FDA Notes Lack Of Proof For Cancer Risk, But Lantus Isn't Out Of The Woods Yet
    In an update to an ongoing safety review, FDA has concluded that proof of an increased risk of cancer with Lantus is lacking, but Sanofi-Aventis SA's blockbuster long-acting insulin analog hasn't been totally cleared and data due out this year may be needed to close the case.]]>     Tue, 11 Jan 2011 00:00:00 GMT     <![CDATA[Millennium Research Group data quoted in Becker’s Orthopedic & Spine Review]]> Volume of Spine Procedures May Recover This Year
    Volume of spine procedures, pushed down last year by reactions to prominent studies questioning the efficacy of some treatments, is expected to bounce back in 2011, according to Matthew O'Brien, an analyst at William Blair & Co.
     

    ]]>     Thu, 06 Jan 2011 00:00:00 GMT     <![CDATA[Manhattan Research data quoted on CMIO.net]]> Mobile Devices: EMR Integration Is Just Beginning
    As the process to convert and integrate EMRs to mobile devices begins, here’s what the mobile-savvy CMIO should expect.
    ]]>     Mon, 03 Jan 2011 00:00:00 GMT     <![CDATA[Millennium Research Group data quoted on Bloomberg.com ]]> Highest-Paid U.S. Doctors Get Rich With Fusion Surgery Debunked by Studies
    Suffering from an aching back, truck driver Mikel Hehn went to see surgeon Jeffrey Gerdes in 2008. The St. Cloud, Minnesota, doctor diagnosed spinal disc degeneration, commonly treated with physical therapy, and said surgery wasn’t called for.

    ]]>     Thu, 30 Dec 2010 13:31:37 GMT     <![CDATA[Millennium Research Group Analyst Emily MacIntosh appeared in Academy News ]]> European and North American implant prices decline
    The economic downturn strongly impacted consumers and companies worldwide, and now its effects on the dental implant industry have become evident.
    ]]>     Mon, 20 Dec 2010 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in FierceBiotech IT]]> App connects dictation, trascription via iPhone
    Catering to the 81 percent of U.S. doctors expected to be using smartphones by 2012, Nuance Communications has launched a mobile point-of-care dictation app connected to speech-enabled transcription platforms and services.
    ]]>     Sat, 18 Dec 2010 00:00:00 GMT     <![CDATA[Millennium Research Group Analyst Adrienne Ma appeared in Diagnostic and Invasive Cardiology]]> Stent Costs Increase Use of Intravascular Imaging
    Optical coherence tomography and fractional flow reserve catheters are expected to see growth
    ]]>     Fri, 17 Dec 2010 00:00:00 GMT     <![CDATA[Manhattan Research data quoted on Mashable.com]]> Why More Health Experts Are Embracing the Social Web
    Is your doctor easily accessible online, or does he or she believe that the Internet isn’t a resource for accessing health information?
    ]]>     Sun, 12 Dec 2010 00:00:00 GMT     <![CDATA[Manhattan Research data quoted on HemOncToday.com]]> Social media and physicians: A good pair, but guidelines for use needed
    In 2004, Kevin Pho, MD, an internist in private practice in Nashua, N.H., launched a blog to discuss breaking medical news. At first, his expectations were low.
    ]]>     Fri, 10 Dec 2010 00:00:00 GMT     <![CDATA[Millennium Research Group data quoted in The Bureau of National Affairs]]> Market Report Forecasts Booming Emergency Room HIT Market Through 2015
    Acute-care hospitals will spend tens of millions of dollars for health information technologies aimed at making their emergency departments and critical care delivery more efficient and less costly, a market intelligence firm said Dec. 1.
    ]]>     Wed, 08 Dec 2010 00:00:00 GMT     <![CDATA[Manhattan Research Senior Director Monique Levy quoted on EyeforPharma.com]]> Nurses and physician assistants: A new pharma marketing channel
    Andrew Tolve reports on how pharma marketers are reaching out to nurses and physician assistants for innovative promotional opportunities
    ]]>     Wed, 08 Dec 2010 00:00:00 GMT     <![CDATA[Millennium Research Group data quoted in DOT Med News]]> University of Washington and GE in patent fight
    University of Washington took General Electric Company to federal court last month in a dispute over patents for integrating ultrasound and MRI or CT images.
    ]]>     Tue, 07 Dec 2010 00:00:00 GMT     <![CDATA[Manhattan Research Director Monique Levy quoted in American Medical News]]> Patients using social media find dubious promotions
    Numerous studies have shown that patients with chronic disease benefit from using social media. But one study might force some who are touting the advantages to add a little caveat.
    ]]>     Mon, 06 Dec 2010 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in Pittsburgh Post-Gazette]]> Online diagnosis: UPMC doctors treating patients over the Internet see benefits
    On Oct. 11, for the first time in his life, Mark Gleeson, 83, got a diagnosis for an illness without seeing a doctor in person, or even speaking to one on a phone.
    ]]>     Mon, 06 Dec 2010 00:00:00 GMT     <![CDATA[Millennium Research Group data quoted in eWEEK]]> GE, Fujifilm Unveil Health Imaging Apps at RSNA 2010
    At the RSNA 2010 conference in Chicago, GE rolled out an image exchange application, and Fujifilm took the wraps off its Synapse Mobility imaging software.
    ]]>     Fri, 03 Dec 2010 00:00:00 GMT     <![CDATA[ Manhattan Research Director Erika S. Fishman appeared in Med Ad News]]> Targeting Women Online
    If the FDA approves Gardasil for older women, Merck will have an interesting marketing challenge on its hands pushing beyond the relatively strong success of its recent campaign targeting younger women.
    ]]>     Fri, 03 Dec 2010 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in HealthLeaders Media]]> Growing eHealth Segment Creates Opportunities for Marketers
    The Internet might create cyberchondriacs, but it can also help healthcare marketers target key patients and track campaign ROI.
    ]]>     Wed, 01 Dec 2010 00:00:00 GMT     <![CDATA[Decision Resources Director Nikhil Mehta quoted in The Pink Sheet]]> Lipitor Study Creates More Doubts On CRP Study Used to Expand Crestor Label
    A new analysis of a large European trial presented at the American Heart Association annual meeting has further damaged the case for using C-reactive protein levels as a guide for statin therapy.
    ]]>     Wed, 01 Dec 2010 00:00:00 GMT     <![CDATA[Decision Resources Analyst Graeme Green, Ph.D. quoted in New Jersey Star Ledger]]> Merck is betting heavily on heart medicines
    The drugmaker’s investment in cardiovascular disease became evident last week when it released new study data supporting the continued development of an experimental drug for treating troublesome cholesterol levels.
    ]]>     Sun, 21 Nov 2010 00:00:00 GMT     <![CDATA[Decision Resources Director Nikhil Mehta quoted in Bloomberg Businessweek]]> Merck Drug Improves Cholesterol Without Safety Risk
    An experimental drug from Merck & Co. raised levels of good cholesterol, slashed bad cholesterol and may have helped patients avert heart complications, without the safety risks that prompted Pfizer Inc. to abandon a similar product four years ago.
    ]]>     Wed, 17 Nov 2010 00:00:00 GMT     <![CDATA[Millennium Research Group data quoted on EndoNurse.com]]> Stats on the GI/Endoscopy Market
    Endoscopy nurses are focused on the clinical side of their professions, rightfully so, but it’s good to stay updated on the business of procedures and the industry at large as well.
    ]]>     Wed, 17 Nov 2010 00:00:00 GMT     <![CDATA[HealthLeaders-InterStudy Analyst Dave Raiford quoted in Columbus Business First]]> Columbus hospitals healthy financially despite economy
    Hospital systems adapted to the sour economy with expense cuts, wage freezes and flexible work scheduling, aggressive debt collection and other measures that helped them do better than many analysts expected.
    ]]>     Tue, 16 Nov 2010 00:00:00 GMT     <![CDATA[Millennium Research Group data quoted in The Annals of Thoracic Surgery]]> Pacemaker and Internal Cardioverter Defibrillator Lead Extraction: A Safe and Effective Surgical Approach
    … perioperative stroke or valve thromboses are the most devastating complications, and some hematoma formation may have to be accepted rather than risk these complications.
    ]]>     Fri, 12 Nov 2010 00:00:00 GMT     <![CDATA[Decision Resources, Inc. Relocates Global Corporate Headquarters to Burlington, MA to Plan for Future Growth]]> ]]> Tue, 26 Oct 2010 08:00:00 GMT <![CDATA[Decision Resources, Inc. Relocates Global Corporate Headquarters to Burlington, MA to Plan for Future Growth]]> ]]> Tue, 26 Oct 2010 08:00:00 GMT <![CDATA[Decision Resources, Inc. CEO Peter Hoenigsberg quoted on MrWeb]]> Decision Resources, Inc. Relocates to Prepare for Growth
    US pharma and healthcare specialist Decision Resources, Inc. has relocated its headquarters from Waltham to Burlington, Massachusetts, in preparation for future growth.
    ]]>     Tue, 26 Oct 2010 00:00:00 GMT     <![CDATA[HealthLeaders-InterStudy data quoted in Crain’s Chicago Business]]> Blue Cross keeps grip on Chicago market
    A study by the American Medical Assn. underscores a widely recognized reality about the health-insurance market in the Chicago area: It's dominated by Blue Cross & Blue Shield of Illinois.
    ]]>     Mon, 25 Oct 2010 11:45:52 GMT     <![CDATA[Manhattan Research Senior Director Monique Levy quoted on FierceOnlineVideo.com ]]> More consumers turning to online video for prescription drug info
    The number of U.S. adults who watch online video for information about prescription drugs more than doubled from 2007 to 2009, a new study says.
    ]]>     Mon, 18 Oct 2010 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in eMarketer Daily]]> Online Video Big Draw on Health Sites for Marketers and Consumers
    Pharma and healthcare marketers find their targets watching videos
    ]]>     Mon, 18 Oct 2010 00:00:00 GMT     <![CDATA[Manhattan Research Vice President Meredith Ressi quoted in eMarketer Daily ]]> Physicians Spend More Time Online
    Internet top resource doctors use for health and medical info
    ]]>     Mon, 04 Oct 2010 00:00:00 GMT     <![CDATA[Decision Resources Director Michael Malecki quoted in <i>In Vivo</i> Magazine]]> Opening A Door To Biosimilars In The US
    With the regulatory door ajar, companies across the industry are vying to dominate the space, despite the commercial risks.
     

    ]]>     Fri, 01 Oct 2010 12:16:21 GMT     <![CDATA[Millennium Research Group data quoted in Medical Device Daily]]> Report scopes competitors in EU gastric band space
    While Ethicon Endo-Surgery (Cincinnati) and Allergan (Irvine, California) remain in top place in the European gastric band device market, other companies are competing for third place, according to the Millennium Research Group (MRG; Toronto).
    ]]>     Fri, 01 Oct 2010 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in Med Ad News]]> How social context is changing the meaning of healthcare marketing
    Marketers need to be aware of the social context of their brands - and to do that, they need to listen.
    ]]>     Fri, 01 Oct 2010 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in CIO Magazine]]> Inside A Smartphone Rollout With Life and Death Consequences
    Tired of carrying around pagers, doctors at Emory Southern University Hospital wanted to receive pages on their BlackBerries, iPhones and Androids.
    ]]>     Fri, 01 Oct 2010 00:00:00 GMT     <![CDATA[MRG quoted in eWeek]]> GE Leads in Ultrasound Market: Report
    A report by the Millennium Research Group shows that GE Healthcare was the leader in the ultrasound market for 2009 and is poised for strong growth through 2014 over Philips and Siemens.
    ]]>     Tue, 28 Sep 2010 00:00:00 GMT     <![CDATA[Manhattan Research Senior Analyst James Avallone quoted on For the Record ]]> The iPad Invasion
    Physicians are adopting iPads to monitor vital signs, access EHRs and educate patients.
    ]]>     Sun, 26 Sep 2010 00:00:00 GMT     <![CDATA[Millennium Research Group Manager Ravindra Sharma quoted in DOT Med News]]> Why MRI?
    Big Names in MRI imagine the potential for imaging.]]>     Sat, 25 Sep 2010 12:56:11 GMT     <![CDATA[Manhattan Research Vice President Meredith Ressi quoted in eMarketer Daily]]> What Are The Best Ways to Target Healthcare Providers Online?
    While the big topic today among most pharmaceutical marketers generally has something to do with FDA regulations and DTC marketing on social media, another equally important question is about the healthcare community. As more physicians start using online tools in their daily practice, what are the best ways marketers can reach them?
    ]]>     Thu, 23 Sep 2010 00:00:00 GMT     <![CDATA[Decision Resources Director Nikhil Mehta quoted in The Pink Sheet]]> Clotbusting On the Clock: New Brands Must Establish Themselves Before Improved Plavix Diagnostics Do
    FDA's three-month postponement of a decision on AstraZeneca PLC 's NDA for Brilinta (ticagrelor) may signal more trouble for the long-term viability of the product rather than any concern about its actual approvability.]]>     Thu, 23 Sep 2010 00:00:00 GMT     <![CDATA[Decision Resources Director Nikhil Mehta quoted in The Pink Sheet]]> Clotbusting On the Clock: New Brands Must Establish Themselves Before Improved Plavix Diagnostics Do
    FDA's three-month postponement of a decision on AstraZeneca PLC 's NDA for Brilinta (ticagrelor) may signal more trouble for the long-term viability of the product rather than any concern about its actual approvability.]]>     Thu, 23 Sep 2010 00:00:00 GMT     <![CDATA[Decision Resources Director Michael Malecki, Ph.D. quoted on the Pharmaceutical Executive web site]]>
    Shakespeare said it best: to be or not to be? It’s decision time for Big Pharma on entering the biosimilar space.]]>     Wed, 22 Sep 2010 00:00:00 GMT     <![CDATA[Decision Resources Director Nikhil Mehta quoted on The Pink Sheet]]>
    FDA's three-month postponement of a decision on AstraZeneca PLC 's NDA for Brilinta (ticagrelor) may signal more trouble for the long-term viability of the product rather than any concern about its actual approvability.]]>     Wed, 22 Sep 2010 00:00:00 GMT     <![CDATA[Millennium Research Group Manager Kevin Flewwelling quoted Silicon Valley/San Jose Business Journal]]> Startups Search for Better Back Surgery
    Some operations for patients with severe back pain could involve major incisions and nearly a week’s hospital stay. But startup San Francisco Bay Area medical device firms have developed far less invasive spinal surgeries they believe are revolutionizing the industry while improving patient care.

    ]]>     Wed, 22 Sep 2010 00:00:00 GMT     <![CDATA[Decision Resources Product Director Michael Malecki, Ph.D. quoted in Pharmaceutical Executive ]]> Biosimilars: This Decade's Most Disruptive Technology
    Shakespeare said it best: to be or not to be? It’s decision time for Big Pharma on entering the biosimilar space.]]>     Wed, 22 Sep 2010 00:00:00 GMT     <![CDATA[Manhattan Research Senior Director Monique Levy quoted in DTC Perspectives ]]> Digital Review: Exploring Consumer Healthcare Web Sites
    Consumer healthcare Web sites play a vital role in consumers’ research, and digital campaigns are gaining traction among DTC marketing budgets. DTC Perspectives examined this role and in addition to a channel overview of trends and DTC efforts, also individually reviewed the top five digital sources, according to comScore data.

    ]]>     Wed, 22 Sep 2010 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in PM 360]]> Unbranded Initiatives Put the Patient First and Build Brand Value
    Regulatory scrutiny of branded marketing campaigns, the consumer appetite for health information, and the rise of the Internet are creating the “perfect storm” for unbranded marketing strategies to make a difference.]]>     Wed, 22 Sep 2010 00:00:00 GMT     <![CDATA[Manhattan Research Analyst Maureen Malloy appeared in DTC Perspectives ]]> What is the Role of Unbranded Websites in Pharmaceutical Digital Marketing?
    In the current DTC marketing landscape, branded initiatives are the predominant form of promotion. According to data from SDI & Kantar Media, unbranded advertising only accounted for about 4% of total DTC spend in 2009.]]>     Wed, 22 Sep 2010 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in PM 360]]> GUEST COMMENTARY
    Marketing Pull]]>     Tue, 21 Sep 2010 00:00:00 GMT     <![CDATA[Decision Resources Directors Stephan Gauldie, Ph.D. and Michael Malecki, Ph.D. quoted in The Pink Sheet]]> Biosimilar Threat Looms For J&J, Amgen And Others, Decision Resources Forecasts
    Among drug makers, Johnson & Johnson and Amgen stand to lose the largest percent of cumulative biologic revenues over the 10-year time period from 2009 to 2019 because of biosimilar competition to their brands, according to the research firm Decision Resources.]]>     Mon, 20 Sep 2010 11:35:29 GMT     <![CDATA[Decision Resources Directors Stephan Gauldie, Ph.D. and Michael Malecki, Ph.D. quoted on The Pink Sheet ]]>
    Among drug makers, Johnson & Johnson and Amgen stand to lose the largest percent of cumulative biologic revenues over the 10-year time period from 2009 to 2019 because of biosimilar competition to their brands, according to the research firm Decision Resources.]]>     Mon, 20 Sep 2010 00:00:00 GMT     <![CDATA[Millennium Research Group data quoted in eWeek]]> GE Tests Smart Patient Room to Monitor Patient Safety, Cut Medical Errors
    GE begins trials of its Smart Patient Room health-monitoring project at New York's Bassett Medical Center to keep hospitals sanitary and to eliminate medical errors.
    ]]>     Thu, 16 Sep 2010 00:00:00 GMT     <![CDATA[Manhattan Research data quoted in TechNewsDaily]]> Dell Wants Doctors to Use the Streak Tablet
    Dell announced that it is integrating healthcare software commonly used by doctors into its Streak tablet in an effort to bring tablets into the doctor's office.]]>     Wed, 15 Sep 2010 15:43:00 GMT     <![CDATA[Manhattan Research quoted in CNET]]> Dell goes after doctors with Streak tablet
    The Streak is coming to hospitals near you.]]>     Wed, 15 Sep 2010 00:00:00 GMT     <![CDATA[Decision Resources Director Nikhil Mehta and Analyst Matthew Killeen quoted on the New Jersey Star Ledger web site]]> Tue, 14 Sep 2010 14:55:49 GMT <![CDATA[Decision Resources Director Donny Wong, Ph.D. quoted on the New Jersey Star Ledger web site]]> Wed, 08 Sep 2010 14:55:49 GMT <![CDATA[Manhattan Research data quoted in SmartMoney Magazine]]> Tue, 07 Sep 2010 17:27:11 GMT <![CDATA[Manhattan Research Vice President Meredith Ressi quoted on FierceMobileHealthcare web site]]> ]]> Tue, 31 Aug 2010 15:36:08 GMT <![CDATA[Decision Resources Analyst Matthew Killeen, Ph.D. quoted on The Pink Sheet ]]> Tue, 31 Aug 2010 00:00:00 GMT <![CDATA[Manhattan Research data quoted on the MarketingCharts web site]]> ]]> Fri, 27 Aug 2010 00:00:00 GMT <![CDATA[Manhattan Research Vice President Meredith Ressi quoted on American Medical News]]> ]]> Mon, 23 Aug 2010 15:36:08 GMT <![CDATA[Millennium Research Group data quoted in the Minneapolis Star Tribune]]> ]]> Sat, 14 Aug 2010 18:31:37 GMT <![CDATA[HealthLeaders-InterStudy Director Jane Dubose quoted in Minneapolis Star Tribune ]]> ]]> Sat, 14 Aug 2010 16:45:52 GMT <![CDATA[Millennium Research Group Manager Kevin Flewwelling was quoted in Silicon Valley/San Jose Business Journal]]> Fri, 13 Aug 2010 21:05:22 GMT <![CDATA[Manhattan Research Vice President Meredith Abreu Ressi quoted in Oncology NEWS International]]> ]]> Tue, 10 Aug 2010 15:32:48 GMT <![CDATA[Manhattan Research data quoted on Nurses.com]]> ]]> Mon, 09 Aug 2010 19:35:53 GMT <![CDATA[Manhattan Research data quoted on American Medical News]]> ]]> Mon, 09 Aug 2010 19:35:53 GMT <![CDATA[Millennium Research Group data quoted in Minneapolis Star Tribune]]> ]]> Mon, 09 Aug 2010 18:31:37 GMT <![CDATA[Manhattan Research Healthcare Marketing Analyst Maureen Malloy quoted in eyeforpharma]]> Mon, 09 Aug 2010 15:53:24 GMT <![CDATA[Manhattan Research data quoted in Pharma 2.0 Blog]]> ]]> Wed, 04 Aug 2010 06:00:00 GMT <![CDATA[Manhattan Research Vice President Meredith Abreu Ressi quoted in San Jose Mercury News]]> ]]> Tue, 03 Aug 2010 15:32:48 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted in Macworld Australia]]> ]]> Mon, 02 Aug 2010 06:00:00 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted in AARP]]> ]]> Thu, 29 Jul 2010 06:00:00 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted in Bloomberg Businessweek and PC World]]> ]]> Thu, 29 Jul 2010 06:00:00 GMT <![CDATA[HealthLeaders-InterStudy Market Analyst Taylor Holliday quoted in Crain’s Cleveland Business journal ]]> ]]> Mon, 26 Jul 2010 00:00:00 GMT <![CDATA[Millennium Research Group data quoted on Bloomberg.com ]]> ]]> Fri, 23 Jul 2010 18:31:37 GMT <![CDATA[Millennium Research Group data quoted on Bloomberg.com ]]> ]]> Fri, 23 Jul 2010 18:31:37 GMT <![CDATA[Decision Resources Analyst Natalie Taylor, Ph.D. quoted on The Pink Sheet ]]> Thu, 22 Jul 2010 05:00:00 GMT <![CDATA[Manhattan Research data quoted in Medical Marketing & Media magazine]]> ]]> Thu, 22 Jul 2010 00:00:00 GMT <![CDATA[Millennium Research Group Senior Analyst Tiffanie Demone was quoted in CNN’s online health blog]]> Wed, 21 Jul 2010 21:05:22 GMT <![CDATA[Millennium Research Group data quoted in the Milwaukee Journal Sentinel]]> ]]> Sat, 17 Jul 2010 18:31:37 GMT <![CDATA[Millennium Research Group Senior Analyst Tiffanie Demone was quoted in the Minneapolis Star Tribune ]]> Fri, 16 Jul 2010 21:05:22 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted in Medical Marketing & Media]]> ]]> Thu, 15 Jul 2010 06:00:00 GMT <![CDATA[Decision Resources Director Donny Wong, Ph.D. quoted on MedPage Today ]]> Tue, 13 Jul 2010 00:00:00 GMT <![CDATA[Manhattan Research Senior Analyst James Avallone's article appeared in Med Ad News ]]> Thu, 08 Jul 2010 21:05:22 GMT <![CDATA[Decision Resources Analyst Matthew Killeen, Ph.D. quoted on the In Pharm web site]]> Mon, 28 Jun 2010 00:00:00 GMT <![CDATA[Manhattan Research data quoted on Pharmaceutical Marketing web site]]> ]]> Thu, 17 Jun 2010 15:10:59 GMT <![CDATA[Manhattan Research Senior Director Monique Levy and Healthcare Marketing Analyst Maureen Malloy quoted in PM360 magazine]]> Thu, 17 Jun 2010 15:05:22 GMT <![CDATA[Manhattan Research Analyst Maureen Malloy quoted on PharmaLive]]> Wed, 16 Jun 2010 16:56:02 GMT <![CDATA[Decision Resources Analyst Alasdair Milton, Ph.D. quoted on boston.com ]]> Wed, 16 Jun 2010 05:00:00 GMT <![CDATA[Millennium Research Group Senior Analyst Melissa Hussey quoted on Bloomberg.com]]> ]]> Fri, 11 Jun 2010 15:47:26 GMT <![CDATA[Millennium Research Group Senior Analyst Melissa Hussey quoted on Bloomberg.com]]> Fri, 11 Jun 2010 15:47:26 GMT <![CDATA[Millennium Research Group Senior Analyst Edward Park in Academy News]]> Wed, 09 Jun 2010 10:45:14 GMT <![CDATA[Manhattan Research Vice President Meredith Ressi quoted on Los Angeles Times website]]> ]]> Mon, 07 Jun 2010 13:50:00 GMT <![CDATA[Manhattan Research data quoted on CNN.com]]> ]]> Mon, 07 Jun 2010 13:35:53 GMT <![CDATA[Manhattan Research data quoted on CNN.com]]> Mon, 07 Jun 2010 13:35:53 GMT <![CDATA[Decision Resources data quoted on Daily News & Analysis website]]> ]]> Fri, 04 Jun 2010 13:30:58 GMT <![CDATA[Manhattan Research data quoted on iHealthBeat web site]]> ]]> Wed, 02 Jun 2010 15:51:57 GMT <![CDATA[Millennium Research Group data quoted on ORTHOSuperSite]]> ]]> Wed, 02 Jun 2010 11:38:21 GMT <![CDATA[Manhattan Research Vice President Meredith Ressi quoted in Med Ad News magazine]]> ]]> Sun, 30 May 2010 13:50:00 GMT <![CDATA[Manhattan Research Senior Director Monique Levy 's article in PM360 magazine ]]> ]]> Sun, 30 May 2010 00:00:00 GMT <![CDATA[Millennium Research Group data quoted on the Plastics News web site]]> ]]> Wed, 26 May 2010 12:31:37 GMT <![CDATA[Millennium Research Group data quoted on TheStreet.com]]> ]]> Wed, 26 May 2010 12:31:37 GMT <![CDATA[HealthLeaders-InterStudy Senior Market Analyst Roy Moore quoted in Crain’s Chicago Business]]> ]]> Mon, 17 May 2010 09:37:53 GMT <![CDATA[Millennium Research Group data quoted in The Associated Press]]> Fri, 14 May 2010 12:09:47 GMT <![CDATA[Manhattan Research data quoted in Medical Marketing & Media magazine]]> ]]> Fri, 14 May 2010 10:55:48 GMT <![CDATA[Manhattan Research data quoted in Medical Marketing & Media magazine]]> ]]> Tue, 11 May 2010 14:03:03 GMT <![CDATA[Millennium Research Group Senior Analyst Stephanie Labelle's appeared on dicardiology.net ]]> ]]> Mon, 10 May 2010 14:41:44 GMT <![CDATA[Millennium Research Group data quoted on Minyanville.com]]> ]]> Thu, 06 May 2010 12:09:47 GMT <![CDATA[Manhattan Research Vice President Meredith Ressi quoted on MobiHealthNews]]> ]]> Wed, 05 May 2010 09:32:48 GMT <![CDATA[Manhattan Research data quoted on MobiHealthNews]]> ]]> Wed, 05 May 2010 09:32:48 GMT <![CDATA[Manhattan Research data quoted in PharmaVOICE]]> Mon, 03 May 2010 09:53:24 GMT <![CDATA[Decision Resources Director Donny Wong, Ph.D. quoted on Bloomberg.com]]> ]]> Fri, 30 Apr 2010 00:00:00 GMT <![CDATA[Decision Resources Director Donny Wong, Ph.D. quoted on Bloomberg.com]]> ]]> Fri, 30 Apr 2010 00:00:00 GMT <![CDATA[HealthLeaders-InterStudy Director Jane Dubose quoted in Chattanooga Times Free Press]]> ]]> Mon, 26 Apr 2010 10:45:52 GMT <![CDATA[Manhattan Research data quoted in Indianapolis Business Journal ]]> Sat, 24 Apr 2010 09:53:24 GMT <![CDATA[HealthLeaders-InterStudy Director Jane Dubose quoted in Chattanooga Times Free Press]]> ]]> Fri, 23 Apr 2010 10:50:26 GMT <![CDATA[Manhattan Research data quoted on iHealthBeat]]> Thu, 22 Apr 2010 09:53:24 GMT <![CDATA[HealthLeaders-InterStudy Analyst Josh Kelley quoted in Tampa Bay Business Journal ]]> ]]> Fri, 16 Apr 2010 10:45:52 GMT <![CDATA[Manhattan Research Senior Analyst James Avallone's article on PharmaLive]]> Thu, 15 Apr 2010 10:56:02 GMT <![CDATA[Millennium Research Group Manager Stephanie Labelle and Analyst Andrea Bettello quoted on Medical Device Daily]]> ]]> Thu, 15 Apr 2010 10:38:08 GMT <![CDATA[Manhattan Research data quoted on ScientificAmerican.com]]> Mon, 12 Apr 2010 09:53:24 GMT <![CDATA[HealthLeaders-InterStudy Analyst Don Mooradian quoted on timesfreepress.com]]> ]]> Fri, 09 Apr 2010 09:37:53 GMT <![CDATA[Manhattan Research President Joe Farris quoted on EyeforPharma.com]]> ]]> Tue, 06 Apr 2010 09:32:48 GMT <![CDATA[Millennium Research Group data quoted on Bloomberg.com ]]> ]]> Tue, 06 Apr 2010 09:27:52 GMT <![CDATA[Decision Resources Analyst Iva Holder, Ph.D. quoted on BioWorld Online]]> Mon, 05 Apr 2010 16:45:03 GMT <![CDATA[Manhattan Research Vice President Meredith Ressi quoted in SmartMoney]]> ]]> Thu, 01 Apr 2010 16:37:26 GMT <![CDATA[Manhattan Research data quoted on iHealthBeat web site]]> ]]> Wed, 24 Mar 2010 00:00:00 GMT <![CDATA[Manhattan Research data quoted on American Medical News]]> ]]> Mon, 22 Mar 2010 14:03:03 GMT <![CDATA[New Marketrack360™ Forecasts Company-Reported Business Segment Sales Prior to Earnings Releases]]> Mon, 22 Mar 2010 00:00:00 GMT <![CDATA[Manhattan Research data quoted in CURE Magazine]]> ]]> Fri, 19 Mar 2010 13:56:17 GMT <![CDATA[Manhattan Research data quoted in Maclean’s magazine]]> ]]> Thu, 18 Mar 2010 13:50:16 GMT <![CDATA[HealthLeaders-InterStudy Analyst Don Mooradian quoted in Chattanooga Times Free Press]]> Thu, 18 Mar 2010 13:44:38 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted in DTC INSIGHTS]]> Tue, 16 Mar 2010 00:00:00 GMT <![CDATA[Manhattan Research Director Erika S. Fishman quoted in PM360]]> ]]> Mon, 15 Mar 2010 14:03:03 GMT <![CDATA[Manhattan Research data quoted in HealthLeaders magazine]]> ]]> Mon, 15 Mar 2010 14:03:03 GMT <![CDATA[Millennium Research Group data quoted in The Gray Sheet ]]> ]]> Mon, 15 Mar 2010 12:09:47 GMT <![CDATA[Millennium Research Group article by Analyst Dan Whalen in Diagnostic & Invasive Cardiology magazine]]> ]]> Thu, 11 Mar 2010 09:34:18 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted on ITWeb]]> Thu, 11 Mar 2010 00:00:00 GMT <![CDATA[Manhattan Research data quoted in Medical Marketing & Media magazine ]]> ]]> Thu, 11 Mar 2010 00:00:00 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted on Fierce Mobile Healthcare web site]]> Tue, 09 Mar 2010 00:00:00 GMT <![CDATA[Manhattan Research Vice President Meredith Ressi and Senior Director Monique Levy quoted in DTC INSIGHTS]]> ]]> Mon, 08 Mar 2010 12:06:12 GMT <![CDATA[Millennium Research Group data quoted in The Minneapolis Star Tribune]]> ]]> Sun, 07 Mar 2010 12:09:47 GMT <![CDATA[Decision Resources Therapeutic Area Director Nikhil Mehta quoted on Bloomberg.com]]>
    ]]>     Fri, 05 Mar 2010 09:39:27 GMT     <![CDATA[Millennium Research Group data quoted in blog entry excerpt on Wallet Pop]]> ]]> Thu, 04 Mar 2010 12:09:47 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted in Mobile Enterprise magazine]]> Thu, 04 Mar 2010 00:00:00 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted in Medical Marketing & Media magazine]]> Thu, 04 Mar 2010 00:00:00 GMT <![CDATA[Millennium Research Group data quoted on the Investor’s Business Daily web site]]> ]]> Wed, 03 Mar 2010 12:09:47 GMT <![CDATA[Manhattan Research data quoted on eWEEK.com]]> ]]> Mon, 01 Mar 2010 00:00:00 GMT <![CDATA[Article by Millennium Research Group Analyst Nadia Oviedo appeared in Academy News]]> ]]> Mon, 22 Feb 2010 09:27:50 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted on American Medical News web site]]> Mon, 22 Feb 2010 00:00:00 GMT <![CDATA[Millennium Research Group Analysts Michelle Li and Dan Whalen quoted on dotmed.com]]> ]]> Fri, 19 Feb 2010 09:34:18 GMT <![CDATA[Manhattan Research Senior Director Erika S. Fishman quoted on American Medical News]]> Mon, 15 Feb 2010 10:47:40 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted in Medical Marketing & Media magazine]]> Mon, 15 Feb 2010 00:00:00 GMT <![CDATA[Millennium Research Group data quoted on The Wall Street Journal ]]> Thu, 11 Feb 2010 00:00:00 GMT <![CDATA[Millennium Research Group data quoted on The Wall Street Journal ]]> Thu, 11 Feb 2010 00:00:00 GMT <![CDATA[Decision Resources, Inc. Chief Executive Officer Peter Hoenigsberg quoted on Wall Street Letter]]> Tue, 09 Feb 2010 08:42:49 GMT <![CDATA[Decision Resources Analyst Matthew Winton, Ph.D. quoted on Bloomberg.com]]> ]]> Tue, 02 Feb 2010 13:08:13 GMT <![CDATA[Decision Resources Analyst Matthew Winton, Ph.D. quoted on Bloomberg.com]]> ]]> Tue, 02 Feb 2010 13:08:13 GMT <![CDATA[Millennium Research Group data quoted on The Source ]]> Mon, 01 Feb 2010 13:49:47 GMT <![CDATA[Manhattan Research Senior Director Erika S. Fishman quoted on FierceHealthIT.com]]> ]]> Mon, 01 Feb 2010 13:24:10 GMT <![CDATA[Millennium Research Group Senior Analyst Ravindra Sharma quoted in Medical Dealer]]> ]]> Mon, 01 Feb 2010 13:13:08 GMT <![CDATA[Manhattan Research Vice President Meredith Ressi article on PharmaLive.com]]> When Manhattan Research began looking at the health and information technology trends of U.S. consumers about a decade ago, individuals who researched prescription drug information online, ePharma Consumers, were considered early adopters.]]> Mon, 01 Feb 2010 12:06:12 GMT <![CDATA[Decision Resources, Inc. appeared in The Boston Globe]]> Mon, 01 Feb 2010 08:42:49 GMT <![CDATA[HealthLeaders-InterStudy Assistant Managing Editor Renee Burnham quoted on The Fort Worth Star-Telegram]]> ]]> Sat, 30 Jan 2010 13:54:26 GMT <![CDATA[Decision Resources data quoted on Barrons.com]]> ]]> Wed, 27 Jan 2010 12:32:49 GMT <![CDATA[Manhattan Research Vice President Meredith Ressi quoted on American Medical News]]> ]]> Mon, 25 Jan 2010 12:06:12 GMT <![CDATA[Millennium Research Group data quoted on Canada.com ]]> ]]> Mon, 25 Jan 2010 00:00:00 GMT <![CDATA[Manhattan Research data quoted on Fierce Pharma web site]]> ]]> Fri, 22 Jan 2010 00:00:00 GMT <![CDATA[Decision Resources, Inc. acquisition of BioTrends a blog entry on Philly.com ]]> Thu, 21 Jan 2010 12:56:42 GMT <![CDATA[Manhattan Research Senior Analyst Stephanie LaBelle quoted on The Houston Chronicle ]]> Wed, 20 Jan 2010 00:00:00 GMT <![CDATA[Millennium Research Group Analyst Lisa Shantz quoted in <i>ADVANCE</i> for Healthy Aging ]]> ]]> Tue, 19 Jan 2010 14:41:44 GMT <![CDATA[Decision Resources data quoted on RTTNews web site]]> Tue, 19 Jan 2010 12:32:49 GMT <![CDATA[Decision Resources, Inc. Acquires BioTrends]]> ]]> Tue, 19 Jan 2010 12:32:05 GMT <![CDATA[Manhattan Research Vice President Meredith Ressi quoted in Medical Marketing & Media]]> ]]> Tue, 19 Jan 2010 12:06:12 GMT <![CDATA[Millennium Research Group Analyst Dan Whalen quoted on FDAnews]]> ]]> Tue, 19 Jan 2010 11:58:21 GMT <![CDATA[Decision Resources, Inc. Acquires Biotrends]]> Tue, 19 Jan 2010 11:32:05 GMT <![CDATA[Decision Resources Analyst Michael Latwis quoted on The Pink Sheet ]]> Mon, 18 Jan 2010 00:00:00 GMT <![CDATA[Decision Resources Director Bethany Kiernan, Ph.D. quoted on InPharm web site]]> Mon, 18 Jan 2010 00:00:00 GMT <![CDATA[Manhattan Research data quoted on E-Health Europe ]]> ]]> Fri, 15 Jan 2010 00:00:00 GMT <![CDATA[Decision Resources, Inc. Promotions Highlighted in Medical Marketing & Media]]> Thu, 14 Jan 2010 12:02:01 GMT <![CDATA[Decision Resources, Inc. Announces Key Strategic Promotions Including Chief Commercialization Officer Mark Bard]]> Tue, 12 Jan 2010 00:00:00 GMT <![CDATA[Decision Resources, Inc. Announces Key Strategic Promotions Including Chief Commercialization Officer Mark Bard]]> Tue, 12 Jan 2010 00:00:00 GMT <![CDATA[HealthLeaders-InterStudy Analyst Josh Kelley quoted in Jacksonville Business Journal ]]> Fri, 08 Jan 2010 00:00:00 GMT <![CDATA[Millennium Research Group data quoted on Implant News & Views]]> “The US market for dental implants, which comprises regular- (> 3.0 mm) and small diameter (d” 3.0 mm) dental implant fixtures, final abutments, and other tools, will achieve strong growth through to 2013."]]> Tue, 05 Jan 2010 00:00:00 GMT <![CDATA[Manhattan Research data quoted on American Medical News ]]> ]]> Mon, 04 Jan 2010 00:00:00 GMT <![CDATA[Manhattan Research data quoted on HealthNewsDigest.com]]> ]]> Mon, 04 Jan 2010 00:00:00 GMT <![CDATA[Millennium Research Group Analyst James Kurz quoted on IBJ.com]]> ]]> Sat, 19 Dec 2009 00:00:00 GMT <![CDATA[Manhattan Research data quoted on MarketingVOX]]> ]]> Fri, 18 Dec 2009 00:00:00 GMT <![CDATA[Decision Resources Analyst Ben Kong quoted on PharmaTimes]]> ]]> Tue, 15 Dec 2009 00:00:00 GMT <![CDATA[Millennium Research Group Article by Analyst Edward Park on Academy News]]> Sun, 13 Dec 2009 00:00:00 GMT <![CDATA[Manhattan Research data quoted on HealthLeaders Media ]]> ]]> Fri, 11 Dec 2009 00:00:00 GMT <![CDATA[Millennium Research Group Manager Kevin Flewwelling quoted in The Massachusetts Medical Devices Journal]]> Tue, 08 Dec 2009 00:00:00 GMT <![CDATA[Manhattan Research data quoted on iHealthBeat]]> ]]> Wed, 02 Dec 2009 00:00:00 GMT <![CDATA[Millennium Research Group Senior Analyst Anuk Karunaratn quoted on EP Lab Digest]]> Tue, 01 Dec 2009 00:00:00 GMT <![CDATA[Decision Resources Directors and Analysts quoted on PharmExec.com]]> Tue, 01 Dec 2009 00:00:00 GMT <![CDATA[Millennium Research Group data quoted on Cardiovascular Business web site]]> Mon, 30 Nov 2009 00:00:00 GMT <![CDATA[Millennium Research Group data quoted on TwinCities.com ]]> Fri, 20 Nov 2009 00:00:00 GMT <![CDATA[Decision Resources data quoted on NJ.com]]> Tue, 17 Nov 2009 00:00:00 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted in Pittsburgh Tribune-Review]]> Mon, 16 Nov 2009 00:00:00 GMT <![CDATA[Decision Resources, Inc. Named to Outsell's "10 to Watch" List]]>
    Acquisitions and Expansion of High-Value Product Lines Drive Decision Resources, Inc. Growth]]>     Mon, 09 Nov 2009 00:00:00 GMT     <![CDATA[Decision Resources, Inc. Named to Outsell's "10 to Watch" List]]>
    Acquisitions and Expansion of High-Value Product Lines Drive Decision Resources, Inc. Growth]]>     Mon, 09 Nov 2009 00:00:00 GMT     <![CDATA[Manhattan Research data quoted on BBC News ]]> ]]> Tue, 03 Nov 2009 00:00:00 GMT <![CDATA[Manhattan Research data quoted on BBC News ]]> ]]> Tue, 03 Nov 2009 00:00:00 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted on The Orlando Sentinel]]> Mon, 02 Nov 2009 00:00:00 GMT <![CDATA[Millennium Research Group data quoted on Xconomy]]> Mon, 02 Nov 2009 00:00:00 GMT <![CDATA[Manhattan Research Senior Director Monique Levy quoted on The Orlando Sentinel]]> Mon, 02 Nov 2009 00:00:00 GMT <![CDATA[Manhattan Research data quoted on The Sacramento Bee]]> Mon, 02 Nov 2009 00:00:00 GMT <![CDATA[Decision Resources Analyst Ben Duncan quoted on NJBIZ ]]> ]]> Fri, 30 Oct 2009 00:00:00 GMT <![CDATA[Millennium Research Group Analyst Deanna Vankessel quoted on Medical Device Daily ]]> Fri, 30 Oct 2009 00:00:00 GMT <![CDATA[Decision Resources Analyst Andrea Buurma quoted in Medical Marketing & Media]]> Mon, 26 Oct 2009 00:00:00 GMT <![CDATA[Manhattan Research Senior Director Monique Levy was quoted on the American Medical News website]]> Mon, 26 Oct 2009 00:00:00 GMT <![CDATA[Manhattan Research President and Co-Founder Mark Bard and Senior Director Monique Levy were quoted in Healthcare IT News]]> Thu, 22 Oct 2009 00:00:00 GMT <![CDATA[Millennium Research Group Senior Analyst Darren Navarro was quoted on NJBIZ]]> Mon, 19 Oct 2009 00:00:00 GMT <![CDATA[Millennium Research Group Senior Analyst Ravindra Sharma was quoted on dotmed.com ]]> ]]> Fri, 16 Oct 2009 00:00:00 GMT <![CDATA[Manhattan Research President and Co-Founder Mark Bard quoted in Medical Marketing & Media]]> Thu, 15 Oct 2009 00:00:00 GMT <![CDATA[Decision Resources Analysts Kate Keeping and Graeme Green were quoted on PharmExec.com]]> ]]> Thu, 01 Oct 2009 00:00:00 GMT <![CDATA[Millennium Research Group Analyst Lisa Shantz quoted on Cosmetics Design Web site ]]> Thu, 24 Sep 2009 00:00:00 GMT <![CDATA[Millennium Research Group Analyst Lisa Shantz quoted on Cosmetics Design Web site ]]> Thu, 24 Sep 2009 00:00:00 GMT <![CDATA[HealthLeaders-InterStudy Jane DuBose was quoted on the Times Free Press Web site.]]> Wed, 16 Sep 2009 00:00:00 GMT <![CDATA[HealthLeaders-InterStudy Jane DuBose was quoted on the Times Free Press Web site.]]> Wed, 16 Sep 2009 00:00:00 GMT <![CDATA[Manhattan Research data was quoted on the Medical Marketing & Media Web site.]]> Tue, 08 Sep 2009 00:00:00 GMT <![CDATA[Manhattan Research data was quoted on the Medical Marketing & Media Web site.]]> Fri, 04 Sep 2009 00:00:00 GMT <![CDATA[Decision Resources data was quoted on the FDA News Web site.]]> Thu, 03 Sep 2009 00:00:00 GMT <![CDATA[Manhattan Research data was quoted on the iHealthBeat Web site.]]> Tue, 01 Sep 2009 00:00:00 GMT <![CDATA[Millennium Research Group Lisa Shantz was quoted on The Street Web site.]]> Mon, 17 Aug 2009 00:00:00 GMT <![CDATA[Manhattan Research data and Monique Levy were quoted on the MarketingVOX Web site.]]> Wed, 12 Aug 2009 00:00:00 GMT <![CDATA[Manhattan Research data and Monique Levy were quoted on the MarketingVOX Web site.]]> Wed, 12 Aug 2009 00:00:00 GMT <![CDATA[Manhattan Research data was quoted on the Medical Marketing and Media Online Web site.]]> Mon, 10 Aug 2009 00:00:00 GMT <![CDATA[Millennium Research Group data was quoted on the Bloomberg Web site.]]> Wed, 05 Aug 2009 00:00:00 GMT <![CDATA[Millennium Research Group Kevin Flewwelling was quoted on the American Metal Market Web site.]]> Wed, 05 Aug 2009 00:00:00 GMT <![CDATA[Millennium Research Group data was quoted on the Twin Cities Web site.]]> Wed, 05 Aug 2009 00:00:00 GMT <![CDATA[Decision Resources Michael Latwis was quoted on the BioWorld Online Web site.]]> Mon, 20 Jul 2009 00:00:00 GMT <![CDATA[Millennium Research Group data was quoted on the Wall Street Journal Web site.]]> Thu, 16 Jul 2009 00:00:00 GMT <![CDATA[Millennium Research Group data was quoted on the Wall Street Journal Web site.]]> Thu, 16 Jul 2009 00:00:00 GMT <![CDATA[Decision Resources data was quoted on the FDANews Web site.]]> Tue, 14 Jul 2009 00:00:00 GMT <![CDATA[Manhattan Research data was quoted on the ABC News Web site.]]> Doctors are increasingly bidding farewell to their classic sidekick -- the pager -- and opting for smartphones that do more to help them practice medicine.

    ]]>     Mon, 13 Jul 2009 00:00:00 GMT     <![CDATA[Decision Resources Neil Grubert was quoted on Fierce Pharma Web site.]]> Thu, 09 Jul 2009 00:00:00 GMT <![CDATA[Decision Resources Christine Helliwell was quoted on Reuters Web site.]]> Mon, 06 Jul 2009 00:00:00 GMT <![CDATA[Jeff Stewart Joins Decision Resources, Inc. as Chief Information Officer]]> Mon, 29 Jun 2009 00:00:00 GMT <![CDATA[Millennium Research Group Amy Krohn quoted in New York Times Web site.]]> Thu, 25 Jun 2009 00:00:00 GMT <![CDATA[Manhattan Research data quoted in Crain's new York Business Web site.]]> Wed, 24 Jun 2009 00:00:00 GMT <![CDATA[HealthLeaders-InterStudy Jane DuBose quoted in Los Angeles Times Web site.]]> Wed, 10 Jun 2009 00:00:00 GMT <![CDATA[HealthLeaders-InterStudy Jane DuBose quoted in Los Angeles Times Web site.]]> Wed, 10 Jun 2009 00:00:00 GMT <![CDATA[Manhattan Research Monique Levy quoted in American Medical News Web site.]]> Fri, 29 May 2009 00:00:00 GMT <![CDATA[Manhattan Research data quoted in iHealthBeat Web site.]]> Thu, 28 May 2009 00:00:00 GMT <![CDATA[Millennium Research Group data quoted in ADVANCE for Healthy Aging magazine and on the Web site.]]> Tue, 26 May 2009 00:00:00 GMT <![CDATA[Millennium Research Group data quoted in ADVANCE for Healthy Aging magazine and on the Web site.]]> Tue, 26 May 2009 00:00:00 GMT <![CDATA[Manhattan Research President and Co-Founder Mark Bard quoted on the Los Angeles Times Web site]]> Thu, 30 Apr 2009 00:00:00 GMT <![CDATA[Manhattan Research President and Co-Founder Mark Bard quoted on the Los Angeles Times Web site]]> Thu, 30 Apr 2009 00:00:00 GMT <![CDATA[Manhattan Research President and Co-Founder Mark Bard quoted in the Los Angeles Times Web site]]> Thu, 30 Apr 2009 00:00:00 GMT <![CDATA[Millennium Research Group Senior Analyst Poonam Jassi quoted on the Wall Street Journal Web site]]> Mon, 13 Apr 2009 00:00:00 GMT <![CDATA[Millennium Research Group Senior Analyst Poonam Jassi quoted on the Wall Street Journal Web site]]> Mon, 13 Apr 2009 00:00:00 GMT <![CDATA[Manhattan Research Data quoted on the ClickZ Web site]]> Last week the U.S. Food and Drug Administration wagged its finger at more than a dozen pharmaceutical companies over their use of paid search advertising.]]> Thu, 09 Apr 2009 00:00:00 GMT <![CDATA[Manhattan Research Data quoted on the ClickZ Web site]]> Last week the U.S. Food and Drug Administration wagged its finger at more than a dozen pharmaceutical companies over their use of paid search advertising.]]> Thu, 09 Apr 2009 00:00:00 GMT <![CDATA[Manhattan Research Data quoted on the DMNews Web site]]> Fri, 03 Apr 2009 00:00:00 GMT <![CDATA[Manhattan Research Data quoted on the DMNews Web site]]> Fri, 03 Apr 2009 00:00:00 GMT <![CDATA[Millennium Research Group quoted on the New York Times Web site]]> Thu, 02 Apr 2009 00:00:00 GMT <![CDATA[Millennium Research Group quoted on the New York Times Web site]]> Thu, 02 Apr 2009 00:00:00 GMT <![CDATA[Manhattan Research Data quoted on the CMIO Web site]]> Wed, 01 Apr 2009 00:00:00 GMT <![CDATA[Manhattan Research Data quoted on the CMIO Web site]]> Wed, 01 Apr 2009 00:00:00 GMT <![CDATA[Manhattan Research Data quoted on the iHealthBeat Web site]]> Tue, 31 Mar 2009 00:00:00 GMT <![CDATA[Decision Resources Analyst Michael Latwis quoted on the Pharmaceutical Executive Web site]]> Tue, 31 Mar 2009 00:00:00 GMT <![CDATA[Manhattan Research Data quoted on the Santa Cruz Sentinel Web Site]]> Tue, 31 Mar 2009 00:00:00 GMT <![CDATA[Manhattan Research Data quoted on the iHealthBeat Web site]]> Tue, 31 Mar 2009 00:00:00 GMT <![CDATA[Millennium Research Group quoted on the FDA News Web site]]> Mon, 30 Mar 2009 00:00:00 GMT <![CDATA[Manhattan Research Director Erika S. Fishman quoted on the Cosmetic Surgery Times Web site]]> Fri, 27 Mar 2009 00:00:00 GMT <![CDATA[Manhattan Research Director Erika S. Fishman quoted on the Cosmetic Surgery Times Web site]]> Fri, 27 Mar 2009 00:00:00 GMT <![CDATA[Manhattan Research Director Erika S. Fishman quoted on the Cosmetic Surgery Times Web site]]> Thu, 26 Mar 2009 00:00:00 GMT <![CDATA[Manhattan Research Data quoted on the Modern Medicine Web site]]> Wed, 25 Mar 2009 00:00:00 GMT <![CDATA[Manhattan Research Data quoted on the American Medical News Web site]]> Wed, 25 Mar 2009 00:00:00 GMT <![CDATA[Decision Resources Therapeutic Area Director Donny Wong, Ph.D. quoted on Bloomberg.com Web site ]]> Wed, 18 Mar 2009 00:00:00 GMT <![CDATA[Decision Resources Therapeutic Area Director Donny Wong, Ph.D. quoted on Bloomberg.com Web site ]]> Wed, 18 Mar 2009 00:00:00 GMT <![CDATA[Decision Resources Therapeutic Area Director Donny Wong, Ph.D. quoted on Bloomberg.com Web site ]]> Wed, 18 Mar 2009 00:00:00 GMT <![CDATA[Millennium Research Group data quoted in The Minneapolis Star Tribune and Web site]]> Tue, 17 Mar 2009 09:41:19 GMT <![CDATA[Millennium Research Group data quoted on the Los Angeles Times Web site]]> Mon, 16 Mar 2009 00:00:00 GMT <![CDATA[Millennium Research Group data quoted on the Los Angeles Times Web site]]> Mon, 16 Mar 2009 00:00:00 GMT <![CDATA[Decision Resources Analyst Michael Latwis quoted on the New Jersey Star Ledger Web site]]> Thu, 12 Mar 2009 00:00:00 GMT <![CDATA[Manhattan Research Director Erika S. Fishman quoted on Newsweek Web site]]> Tue, 10 Mar 2009 00:00:00 GMT <![CDATA[Manhattan Research data was quoted on the Pharmaceutical Executive Web site]]> Wed, 04 Mar 2009 00:00:00 GMT <![CDATA[Millennium Research Group data quoted on the Life Sciences World Web site]]> Sat, 28 Feb 2009 00:00:00 GMT <![CDATA[Manhattan Research Senior Director Monique Levy, published in Med Ad News magazine]]> Tue, 24 Feb 2009 00:00:00 GMT <![CDATA[Decision Resources Senior Analyst Nikhil Mehta and Analyst Graeme Green, Ph.D., were quoted on the web site of Medical Marketing & Media magazine]]> Mon, 16 Feb 2009 00:00:00 GMT <![CDATA[Decision Resources data quoted on the New Jersey Star Ledger Web site]]> Sun, 15 Feb 2009 09:41:19 GMT <![CDATA[Manhattan Research data quoted on Medical Marketing & Media magazine Web site]]> Mon, 09 Feb 2009 00:00:00 GMT <![CDATA[Millennium Research Group Senior Analyst Tiffanie Demone quoted in The Orlando Business Journal and on bizjournals.com]]> Thu, 05 Feb 2009 00:00:00 GMT <![CDATA[Decision Resources Director Stephan Gauldie quoted on The Pink Sheet Web site]]> Mon, 02 Feb 2009 09:41:19 GMT <![CDATA[Manhattan Research data quoted on Advertising Age Web site]]> Mon, 02 Feb 2009 00:00:00 GMT <![CDATA[Millennium Research Group Senior Analyst Chris Schutz quoted on MedicExchange Web site]]> Fri, 30 Jan 2009 00:00:00 GMT <![CDATA[Decision Resources data quoted on Barron's Online Web site]]> Thu, 29 Jan 2009 09:41:19 GMT <![CDATA[Manhattan Research Vice President Meredith Abreu Ressi quoted in Health Blog section of The Wall Street Journal Online]]> Wed, 28 Jan 2009 09:41:19 GMT <![CDATA[Manhattan Research data quoted on the Fierce Healthcare Web site]]> Wed, 28 Jan 2009 09:41:19 GMT <![CDATA[Decision Resources Analyst Sandra Chow quoted in Rolling Stone magazine]]> Wed, 28 Jan 2009 09:41:19 GMT <![CDATA[Manhattan Research data quoted on the Management in Practice Web site]]> Mon, 26 Jan 2009 09:41:19 GMT <![CDATA[Manhattan Research data quoted on the iHealthBeat Web site]]> Fri, 23 Jan 2009 09:41:19 GMT <![CDATA[Millennium Research Group data quoted on the Seeking Alpha Web site]]> Wed, 21 Jan 2009 09:41:19 GMT <![CDATA[Millennium Research Group Co-President Aaron Dickson quoted in FDAnews]]> Mon, 19 Jan 2009 13:36:59 GMT <![CDATA[HealthLeaders-InterStudy Director Jane DuBose quoted in The Memphis Business Journal and Web site]]> Fri, 16 Jan 2009 13:36:59 GMT <![CDATA[Manhattan Research Vice President Meredith Abreu Ressi quoted on CNN Web site]]> Thu, 15 Jan 2009 13:36:59 GMT <![CDATA[Millennium Research Group data quoted in The New York Times and Web site]]> Tue, 13 Jan 2009 13:36:59 GMT <![CDATA[Manhattan Research data quoted in The Orlando Sentinel and Web site]]> Mon, 12 Jan 2009 13:36:59 GMT <![CDATA[Millennium Research Group Analyst Priyanka Jain quoted in The Wall Street Journal and Web site]]> Mon, 12 Jan 2009 13:36:59 GMT <![CDATA[HealthLeaders-InterStudy Analyst Rick Byrne quoted in The Indianapolis Business Journal and Web site]]> Sat, 10 Jan 2009 13:36:59 GMT <![CDATA[Millennium Research Group Analyst Ravindra Sharma quoted in the Cardiovascular Business magazine and Web site]]> Fri, 09 Jan 2009 13:36:59 GMT <![CDATA[HealthLeaders-InterStudy Director Jane DuBose quoted in The Tennessean and on the Web site]]> Fri, 09 Jan 2009 09:30:16 GMT <![CDATA[Millennium Research Group Co-President Aaron Dickson quoted on The Hospital Review magazine Web site]]> Thu, 08 Jan 2009 13:36:59 GMT <![CDATA[Manhattan Research Vice President Meredith Abreu Ressi quoted on the iHealthBeat Web site]]> Wed, 07 Jan 2009 09:24:29 GMT <![CDATA[Manhattan Research Director Erika S. Fishman quoted in the American Medical News Web site]]> Mon, 05 Jan 2009 13:36:59 GMT <![CDATA[Manhattan Research Vice President Meredith Abreu Ressi quoted in Money Magazine and Web site]]> Did you wake up with pinkeye? Or maybe a painful sore throat or a nasty rash? You want relief and you want it now. Well, good luck getting it.

    ]]>     Tue, 30 Dec 2008 13:36:59 GMT     <![CDATA[Manhattan Research Vice President Meredith Abreu Ressi published article appearing in Med Ad News magazine]]> Tue, 30 Dec 2008 00:00:00 GMT <![CDATA[Manhattan Research data quoted on PharmaTimes Web site]]> Mon, 22 Dec 2008 13:36:59 GMT <![CDATA[Millennium Research Group data quoted in commentary appearing on Bloomberg.com]]> Mon, 15 Dec 2008 13:36:59 GMT <![CDATA[Manhattan Research data was quoted Medical Marketing & Media magazine Web site]]> Mon, 15 Dec 2008 13:36:59 GMT <![CDATA[Manhattan Research Vice President Meredith Abreu Ressi quoted on eyeforpharma.com]]> Manhattan Research, recently released its US study of consumers - Cybercitizen Health v8.0.

    ]]>     Sun, 14 Dec 2008 13:36:59 GMT     <![CDATA[Millennium Research Group Co-President Aaron Dickson was quoted in USA Today and on their Web site]]> While many businesses struggle during the recession, a handful of U.S. and global companies — from health care giant Abbott Laboratories (ABT) to retail king Wal-Mart (WMT)—are riding out the financial storm in good shape.

    ]]>     Thu, 04 Dec 2008 14:39:06 GMT     <![CDATA[Millennium Research Group Human Resources Manager Geeta Thekkakara quoted in The Globe and Mail of Canada and on theglobeandmail.com.]]> Class of '09: Job hunt may hold some surprises
    By: Eleanor Beaton

    ]]>     Fri, 21 Nov 2008 15:39:06 GMT     <![CDATA[Fingertip Formulary's Web site was featured on the Current Psychiatry Online Web site]]> The article highlights the 12 best Web sites for clinical needs that are available to internet users.

    ]]>     Fri, 21 Nov 2008 14:39:06 GMT     <![CDATA[Millennium Research Group Manager David Plow quoted in FDAnews Web site.]]> By Renee Frojo]]> Mon, 17 Nov 2008 15:19:42 GMT <![CDATA[Manhattan Research President and Co-Founder Mark Bard quoted on NJBIZ Web site]]> Wellness programs may lift drug sales
    By Shankar P.]]>     Mon, 17 Nov 2008 14:15:55 GMT     <![CDATA[Manhattan Research data was quoted in the article below that appeared on the MarketingVOX Web site]]> Fri, 14 Nov 2008 14:03:46 GMT <![CDATA[HealthLeaders-InterStudy Analyst Chris Clancy quoted on the NJBIZ Web site.]]> By Evelyn Lee
    ]]>     Wed, 12 Nov 2008 14:36:59 GMT     <![CDATA[Decision Resources Senior Analyst Nikhil Mehta quoted on PharmExec.com Web site. ]]> Jupiter Study Gives Huge Boost to Crestor
    By George Koroneos

    ]]>     Wed, 12 Nov 2008 14:27:00 GMT     <![CDATA[Decision Resources Principal Analyst Donny Wong, Ph.D., quoted on PharmExec.com Web site]]> CB-1 Antagonists for Obesity: R.I.P.
    By George Koroneos

    ]]>     Wed, 12 Nov 2008 13:36:59 GMT     <![CDATA[Decision Resources data quoted on In-PharmaTechnologist.com Web site.]]> Mon, 10 Nov 2008 14:08:58 GMT <![CDATA[Millennium Research Group data quoted on The New York Times Web site.]]> By Barry Meier]]> Fri, 07 Nov 2008 15:19:42 GMT <![CDATA[Decision Resources Principal Analyst Analyst Michael Latwis quoted on PharmExec.com Web site]]> Sat, 01 Nov 2008 13:36:59 GMT <![CDATA[Manhattan Research Vice President Meredith Abreu Ressi quoted in Med Ad News and on Web site.]]> Sat, 01 Nov 2008 10:39:06 GMT <![CDATA[Manhattan Research Vice President Meredith Abreu Ressi quoted in Med Ad News and Web site]]> For the second year, Med Ad News has chosen four Pharmaceutical Marketing Ventures to Watch from a variety of young, creative venture companies that could change the way pharmaceutical products are marketed and sold. 

    ]]>     Sat, 01 Nov 2008 09:24:29 GMT     <![CDATA[Manhattan Research Vice President Meredith Abreu Ressi quoted in Raleigh Metro magazine and Web site]]> By Anthony Vecchione]]> Sat, 01 Nov 2008 00:00:00 GMT <![CDATA[HealthLeaders-InterStudy Analyst Rick Byrne was quoted on Bloomberg.com.]]> By Avram Goldstein]]> Mon, 27 Oct 2008 00:00:00 GMT <![CDATA[Manhattan Research Director Erika Fishman quoted on macnewsworld.com. ]]> By Erika Morphy

    ]]>     Mon, 27 Oct 2008 00:00:00 GMT     <![CDATA[Millennium Research Group Data Quoted by Dow Jones Newswires and appeared on CNNMoney.com Web site]]> Boston Scientific: 3Q Share Remained Steady For Drug Stents
    By Shirleen Dorman, Dow Jones Newswires

    ]]>     Tue, 21 Oct 2008 10:03:12 GMT     <![CDATA[Decision Resources data quoted on The Economic Times Web site, a financial news service of Indiatimes]]> By Nina Mehta, ET Bureau]]> Sat, 18 Oct 2008 09:52:48 GMT <![CDATA[Decision Resoures, Inc. Named to the Inc. 5000 List ]]> Wed, 15 Oct 2008 08:36:54 GMT <![CDATA[Decision Resoures, Inc. Named to the Inc. 5000 List ]]> Wed, 15 Oct 2008 08:36:54 GMT <![CDATA[Millennium Research Group Quoted on RTTnews.com]]> Tue, 14 Oct 2008 10:03:12 GMT <![CDATA[Decision Resources Analyst Amy Whiting, Ph.D. Quoted on MediaPost Website ]]> by Aaron Baar]]> Thu, 09 Oct 2008 09:48:35 GMT <![CDATA[Millennium Research Group Data Quoted on Dow Jones Financial Information Services Website]]> By Brian Gormley
     
    Some venture capitalists are taking aim at one of America's top killers.]]>     Wed, 08 Oct 2008 11:07:03 GMT     <![CDATA[Manhattan Research Vice President Meredith Abreu Ressi quoted in Medical Marketing & Media magazine]]> By Ben Comer]]> Mon, 06 Oct 2008 11:39:06 GMT <![CDATA[Millennium Research Group Quoted in <i>The Memphis Commercial Appeal</i>]]> Cutting edge: Gyrus busy with new surgical tool, ownership. By Daniel Connolly
     
    Workers at Gyrus ENT are rolling out a new surgical product as they adjust to life under new ownership.
    Earlier this year, the Bartlett manufacturer of surgical products for ear, nose and throat specialists became part of Olympus, a Japanese conglomerate.]]>     Fri, 03 Oct 2008 11:39:06 GMT     <![CDATA[Millennium Research Group Manager Christian Burnaccioni quoted on Technology Marketing Corporation Web site.]]> MRG Uses Strategy Companion's Analyzer for Marketrack SaaS Product
    By Anil Sharma -- TMCnet Contributing Editor

    ]]>     Thu, 02 Oct 2008 10:56:48 GMT     <![CDATA[Decision Resources Analyst Jackie Innes was quoted in Pharmaceutical Executive magazine and on the Web site, PharmExec.com]]> By Catherine Hollingsworth]]> Wed, 01 Oct 2008 00:00:00 GMT <![CDATA[Manhattan Research Article Published in PM360 Magazine ]]> Back to Basics: Getting the Most Out of Brand.com
     
    By: Meredith Abreu Ressi and Maureen Malloy ]]> Thu, 25 Sep 2008 10:35:07 GMT <![CDATA[Millennium Research Group Quoted in Becker's ASC Review ]]> 6 Trends in Minimally Invasive GYN  
    By Stephanie Wasek    

    Increased use of global endometrial ablation (GEA) devices...

    ]]>     Sat, 20 Sep 2008 13:12:05 GMT     <![CDATA[HealthLeaders-InterStudy Analyst Chris Lewis Quoted in <i>Patriot-News of Harrisburg<i/>]]> Insurer's regional focus, reserves keep company competitive, execs saySunday, September 21, 2008
    By David Wenner of the Patriot-News]]>     Sat, 20 Sep 2008 12:56:13 GMT     <![CDATA[Decision Resources Analyst Jing Wu Quoted in PharmAsia News]]> China’s HCV Drug Market To Grow To $150 Million By 2012  

    SHANGHAI - China's hepatitis C virus drug market will grow to $150 million by 2012, according to a report released in September by Decision Resources.]]> Thu, 18 Sep 2008 12:56:19 GMT <![CDATA[Manhattan Research Data Quoted in Medical Marketing & Media Magazine]]> Pfizer brings back tortoise, hare in Chantix extended remix
    By Matthew Arnold

    Nine months after it pulled Chantix DTC amid concern about possible psychiatric side effects, Pfizer's tortoise and hare are back on the air with a new 90-second TV spot long on risk information.]]> Tue, 16 Sep 2008 09:53:32 GMT <![CDATA[Millennium Research Group Quoted in <i>TwinCities.com-Pioneer Press<i/>]]> By Jeremy Olson and Christopher Snowbeck]]> Sat, 13 Sep 2008 11:28:19 GMT <![CDATA[Manhattan Research's Vice President Meredith Abreu Ressi Quoted in <i>The Washington Post</i>]]> What Teens Are Hearing About Drugs
    Some Messages Help, Others Are Troubling

    By Francesca Lunzer Kritz, Special to The Washington Post

    ]]>     Tue, 09 Sep 2008 09:41:58 GMT     <![CDATA[Millennium Research Group Quoted in <i>Wall Street Journal </i>]]> Beauty magazines and spas are touting a new generation of high-tech treatments for cellulite, a common affliction that gives parts of women's bodies a dimpled, uneven appearance. But there's little evidence that the new devices are effective, say some dermatologists who have scoured the medical literature and evaluated the products.]]> Tue, 19 Aug 2008 10:11:32 GMT <![CDATA[HealthLeaders-InterStudy's Chris Lewis Quoted in <i>California Healthline Website</i>]]> HMOs Enter Homestretch Before New Language Law Takes Effect
    By George Lauer

    California HMOs are gearing up for a new language assistance law that takes effect in six months. Health plans must provide translated materials and interpretation services to any member who needs it in whatever language or form.]]> Mon, 18 Aug 2008 16:47:43 GMT <![CDATA[HealthLeader-InterStudy's Renee Burnham Quoted in <i>Houston Business Journal</i>]]>
    When Foundation Surgical Hospital and University General Hospital opened their doors in 2006, both physician-owned hospitals had what they thought were solid business plans.]]>     Mon, 11 Aug 2008 12:20:36 GMT     <![CDATA[Manhattan Research's Mark Bard Quoted Promoting the eComm Conference]]> Izzy Wakeling, Head of Global Events

    Challenges and opportunities for today’s pharmaceutical e-marketers abound. From social networking tools and advanced physician portals to streaming video and closed loop strategies, the opportunities to open new communication channels with patients, physicians and other key stakeholders are limited only by a marketer’s imagination and determination.]]>     Fri, 08 Aug 2008 12:20:36 GMT     <![CDATA[Millennium Research Group's David Plow Quoted in <i>Health Imaging News</i>]]> Fri, 08 Aug 2008 12:20:36 GMT <![CDATA[Manhattan Research's Erika S. Fishman Quoted in <i>The Indianapolis Star</i>]]> Improving Health Care With a Card: Community Health program offers patients tech tools, convenience

    By Daniel Lee

    Many people can't imagine banking without an ATM card to grab cash and the Internet to pay bills. And millions of travelers head straight for the electronic check-in kiosk when they get to the airport.]]> Thu, 07 Aug 2008 12:20:36 GMT <![CDATA[Decision Resources' Barbara Bolten Quoted in <i>Pharmaceutical Executive</i>]]> by Walter Armstrong]]> Fri, 25 Jul 2008 09:45:41 GMT <![CDATA[Lori Silver Joins Decision Resources, Inc. as General Counsel]]> Thu, 24 Jul 2008 12:09:52 GMT <![CDATA[Manhattan Research Manager Maureen Malloy Quoted in <i>Med Ad News</i>]]> Thu, 24 Jul 2008 09:45:41 GMT <![CDATA[Decision Resources' Michael Latwis Quoted in <i>Bloomberg.com</i>]]> By Lisa Rapaport]]> Thu, 03 Jul 2008 11:10:05 GMT <![CDATA[Millennium Research Group Analyst Nadia Lachowsky Quoted in <i>Becker's ASC Review</i>]]> by Rob Kurtz]]> Thu, 03 Jul 2008 11:06:08 GMT <![CDATA[Decision Resources' principal analyst Donny Wong, Ph.D., was quoted in news article on <i>Bloomberg.com</i>]]> Thu, 26 Jun 2008 00:00:00 GMT <![CDATA[Decision Resources, Inc. Acquires Manhattan Research]]> Mon, 16 Jun 2008 23:00:00 GMT <![CDATA[MRG Quoted on <i>Business Week</i> Website]]> Thu, 12 Jun 2008 00:00:00 GMT <![CDATA[Decision Resources' Data quoted by </i>Reuters</i> appearing on <i>The Guardian website </i>]]> Wed, 11 Jun 2008 00:00:00 GMT <![CDATA[Decision Resources' Donny Wong, Sr. Analyst Quoted on <i>Barron's Online</i>]]> Fri, 06 Jun 2008 00:00:00 GMT <![CDATA[Clair Gricks and Ramya Kollipara Quoted in <i>Pharmaceutical Executive</i>]]> Wed, 04 Jun 2008 00:00:00 GMT <![CDATA[MRG Quoted in <i>Austin Business Journal</i> website]]> Fri, 30 May 2008 00:00:00 GMT <![CDATA[MRG Quoted on the <i>New York Times</i> website]]> Fri, 30 May 2008 00:00:00 GMT <![CDATA[HealthLeaders-InterStudy quoted regarding Dallas' Medical Building Boom is Top in Nation]]> Fri, 23 May 2008 00:00:00 GMT <![CDATA[Renee Burnham, Market Analyst for HealthLeaders-InterStudy quoted in <i>Dallas News</i>]]> Fri, 23 May 2008 00:00:00 GMT <![CDATA[MRG quoted in article on <i>The Telegraph UK</i> Website]]> Sat, 19 Apr 2008 00:00:00 GMT <![CDATA[Decision Resources Quoted in "Amgen Develops Six Cancer Drugs as Anemia Sales Fall" on <i>Bloomberg.com</i>]]> Fri, 11 Apr 2008 00:00:00 GMT <![CDATA[Merrill Lynch to Market Alternative Research Through A New Service Called Merrill Open Minds]]> Wed, 09 Apr 2008 00:00:00 GMT <![CDATA[Decision Resources Quoted on </i>TheStreet.com</i>]]> Fri, 04 Apr 2008 00:00:00 GMT <![CDATA[Decision Resources data quoted on <i>Bloomberg.com</i>]]> Mon, 31 Mar 2008 00:00:00 GMT <![CDATA[Mohamed Muhsin, an oncology analyst with Decision Resources is quoted on <i>NJ.com</i>]]>
    Aside from being a big success financially, Merck's Gardasil vaccine for cervical cancer has nudged up hope vaccines might someday work against other types of cancer. Aside from being a big success financially, Merck's Gardasil vaccine for cervical cancer has nudged up hope vaccines might someday work against other types of cancer.]]>     Wed, 26 Mar 2008 00:00:00 GMT     <![CDATA[Decision Resources, Inc. Acquires Fingertip Formulary]]> Sun, 16 Mar 2008 23:00:00 GMT <![CDATA[MRG Data Quoted on <i>Reuters.com</i>]]> Tue, 19 Feb 2008 00:00:00 GMT <![CDATA[Decision Resources, Inc. Acquires Arlington Medical Resources, Inc.]]> Tue, 18 Dec 2007 23:00:00 GMT <![CDATA[Decision Resources, Inc. to Acquire Wood Mackenzie's Life Sciences Business]]> Mon, 03 Dec 2007 23:00:00 GMT <![CDATA[Providence Equity Partners Acquires Majority Control of Decision Resources]]> Sun, 20 May 2007 23:00:00 GMT <![CDATA[Decision Resources, Inc. Acquires Millennium Research Group]]> Wed, 01 Feb 2006 23:00:00 GMT <![CDATA[Decision Resources, Inc. Acquires Metropolitan Market Analysis Product Line from Health Strategies Group, Inc.]]> Acquisition Adds To the Already Robust Managed Care and Health Care Market Intelligence Portfolio from HealthLeaders-InterStudy
    ]]>     Wed, 13 Apr 2005 23:00:00 GMT